| Symbol | BDX |
|---|---|
| Name | BECTON DICKINSON & CO |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | ONE BECTON DR, FRANKLIN LAKES, NJ 07417-1880 |
| Telephone | 2018476800 |
| Fax | — |
| — | |
| Website | https://www.bd.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000010795 |
| Description | Becton, Dickinson is the worlds largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the companys business. Additional info from NASDAQ: |
2026-08-17 20:31
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
Read more
2026-08-17 20:30
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
Read more
2026-08-14 20:36
Director Polen Thomas E Jr 🟡 adjusted position in 43.3K shares (1 derivative) of BECTON DICKINSON & CO (BDX) at $185.00 ($22.5M) Transaction Date: Aug 13, 2026 | Filing ID: 057166
Read more
2026-08-12 21:27
Goette Roland 🔴 sold 2.4K shares of BECTON DICKINSON & CO (BDX) at $180.84 Transaction Date: Aug 11, 2026 | Filing ID: 056366
Read more
2026-08-12 10:51
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
Read more
2026-08-12 10:50
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
Read more
2026-08-11 15:58
📋 Roland Goette (Officer) plans to sell 2K shares of Becton, Dickinson and Company (at $180.84 each, total $441K) Filed: Aug 11, 2026 | ID: 055581
Read more
2026-08-07 09:47
New Form SCHEDULE 13G - BECTON DICKINSON & CO <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0000093751-26-000419 <b>Size:</b> 8 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07769086 | Breakthrough Platform Trial for PCAS | Na | Cardiac Arrest (CA) | Not_Yet_Recruiting | 2026-09-01 | 2031-06-30 | ClinicalTrials.gov |
| NCT07769086 | Breakthrough Platform Trial for PCAS | Na | Cardiac Arrest (CA) | Not_Yet_Recruiting | 2026-09-01 | 2031-06-30 | ClinicalTrials.gov |
| NCT07744945 | Evaluation of Male and Female External Catheters for Urine Output Monitoring in… | — | Urine Output | Not_Yet_Recruiting | 2026-08-01 | 2026-10-01 | ClinicalTrials.gov |
| NCT07744945 | Evaluation of Male and Female External Catheters for Urine Output Monitoring in… | — | Urine Output | Not_Yet_Recruiting | 2026-08-01 | 2026-10-01 | ClinicalTrials.gov |
| NCT06934486 | Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung… | — | Post-operative Air Leaks | Not_Yet_Recruiting | 2026-07-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT06934486 | Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung… | — | Post-operative Air Leaks | Not_Yet_Recruiting | 2026-07-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07216573 | The Continuity Study | Na | Blood Pressure | Recruiting | 2026-05-07 | 2027-02-01 | ClinicalTrials.gov |
| NCT07216573 | The Continuity Study | Na | Blood Pressure | Recruiting | 2026-05-07 | 2027-02-01 | ClinicalTrials.gov |
| NCT07282860 | An Evaluation of the PureWick™ Male External Catheter Versus an Established Com… | Na | Urinary Incontinence | Completed | 2025-11-21 | 2026-06-22 | ClinicalTrials.gov |
| NCT07282860 | An Evaluation of the PureWick™ Male External Catheter Versus an Established Com… | Na | Urinary Incontinence | Completed | 2025-11-21 | 2026-06-22 | ClinicalTrials.gov |
| NCT06632509 | BD SiteRite(TM) 9 Ultrasound System - Clinical Study | — | BD SiteRite 9 for VAD Insertion | Completed | 2025-11-12 | 2026-01-09 | ClinicalTrials.gov |
| NCT06632509 | BD SiteRite(TM) 9 Ultrasound System - Clinical Study | — | BD SiteRite 9 for VAD Insertion | Completed | 2025-11-12 | 2026-01-09 | ClinicalTrials.gov |
| NCT07317648 | ClearSight NextGen1 Study | Na | Blood Pressure | Completed | 2025-10-16 | 2026-03-05 | ClinicalTrials.gov |
| NCT07317648 | ClearSight NextGen1 Study | Na | Blood Pressure | Completed | 2025-10-16 | 2026-03-05 | ClinicalTrials.gov |
| NCT07148323 | HemoSphere Alta Study | — | Hemodynamic Instability | Active_Not_Recruiting | 2025-10-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT07148323 | HemoSphere Alta Study | — | Hemodynamic Instability | Active_Not_Recruiting | 2025-10-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT07016698 | Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System… | Na | Peripheral Arterial Disease(PAD) | Recruiting | 2025-09-29 | 2029-05-31 | ClinicalTrials.gov |
| NCT07016698 | Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System… | Na | Peripheral Arterial Disease(PAD) | Recruiting | 2025-09-29 | 2029-05-31 | ClinicalTrials.gov |
| NCT06806709 | Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw D… | Na | Blood Culture Contamination | Recruiting | 2025-08-18 | 2026-12-31 | ClinicalTrials.gov |
| NCT06806709 | Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw D… | Na | Blood Culture Contamination | Recruiting | 2025-08-18 | 2026-12-31 | ClinicalTrials.gov |
| NCT06632496 | BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking… | — | BD Prevue II for Peripheral Intravenous Catheter Placement | Completed | 2025-03-28 | 2025-09-23 | ClinicalTrials.gov |
| NCT06632496 | BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking… | — | BD Prevue II for Peripheral Intravenous Catheter Placement | Completed | 2025-03-28 | 2025-09-23 | ClinicalTrials.gov |
| NCT06850259 | This Study Will Collect Clinical and Patient Reported Satisfaction Data From Ma… | Na | Urinary Incontinence | Completed | 2025-03-21 | 2025-06-15 | ClinicalTrials.gov |
| NCT06850259 | This Study Will Collect Clinical and Patient Reported Satisfaction Data From Ma… | Na | Urinary Incontinence | Completed | 2025-03-21 | 2025-06-15 | ClinicalTrials.gov |
| NCT06822036 | EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATI… | Na | Prostate Cancer (Adenocarcinoma) | Recruiting | 2025-01-16 | 2027-01-30 | ClinicalTrials.gov |
| NCT06822036 | EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATI… | Na | Prostate Cancer (Adenocarcinoma) | Recruiting | 2025-01-16 | 2027-01-30 | ClinicalTrials.gov |
| NCT05945329 | Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Bre… | Na | Capsular Contracture Associated With Breast Implant | Recruiting | 2024-12-12 | 2029-02-01 | ClinicalTrials.gov |
| NCT05945329 | Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Bre… | Na | Capsular Contracture Associated With Breast Implant | Recruiting | 2024-12-12 | 2029-02-01 | ClinicalTrials.gov |
| NCT06666426 | This Study Will Collect Clinical and Patient Reported Experience Data From Part… | Na | Adult Nocturnal Enuresis | Completed | 2024-10-31 | 2025-06-30 | ClinicalTrials.gov |
| NCT06666426 | This Study Will Collect Clinical and Patient Reported Experience Data From Part… | Na | Adult Nocturnal Enuresis | Completed | 2024-10-31 | 2025-06-30 | ClinicalTrials.gov |
| NCT06604026 | Investigational Study With the BD PosiFlush™ SafeScrub on NADs | Na | CRBSI - Catheter Related Bloodstream Infection | Recruiting | 2024-10-22 | 2026-02-28 | ClinicalTrials.gov |
| NCT06604026 | Investigational Study With the BD PosiFlush™ SafeScrub on NADs | Na | CRBSI - Catheter Related Bloodstream Infection | Recruiting | 2024-10-22 | 2026-02-28 | ClinicalTrials.gov |
| NCT06631313 | PureWick™ Adolescent Study | Na | Healthy Volunteers, Adolescent | Completed | 2024-08-28 | 2024-09-25 | ClinicalTrials.gov |
| NCT06631313 | PureWick™ Adolescent Study | Na | Healthy Volunteers, Adolescent | Completed | 2024-08-28 | 2024-09-25 | ClinicalTrials.gov |
| NCT06426121 | Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equiv… | — | Sepsis | Completed | 2024-06-26 | 2025-10-23 | ClinicalTrials.gov |
| NCT06426121 | Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equiv… | — | Sepsis | Completed | 2024-06-26 | 2025-10-23 | ClinicalTrials.gov |
| NCT06492746 | Personal BP - CAI Study | Na | Blood Pressure | Recruiting | 2024-06-03 | 2027-01-01 | ClinicalTrials.gov |
| NCT06492746 | Personal BP - CAI Study | Na | Blood Pressure | Recruiting | 2024-06-03 | 2027-01-01 | ClinicalTrials.gov |
| NCT05710718 | PureWick™ France and U.S. At-Home Pilot Study | Na | Nocturnal Enuresis | Completed | 2023-10-31 | 2024-08-25 | ClinicalTrials.gov |
| NCT05710718 | PureWick™ France and U.S. At-Home Pilot Study | Na | Nocturnal Enuresis | Completed | 2023-10-31 | 2024-08-25 | ClinicalTrials.gov |
| NCT06052449 | Assessing Social Determinants of Health to Increase Cancer Screening | Na | Lung Cancer | Completed | 2023-09-30 | 2025-08-19 | ClinicalTrials.gov |
| NCT06052449 | Assessing Social Determinants of Health to Increase Cancer Screening | Na | Lung Cancer | Completed | 2023-09-30 | 2025-08-19 | ClinicalTrials.gov |
| NCT05504070 | Venclose digiRF System Post Market Study | Na | Venous Reflux | Active_Not_Recruiting | 2023-09-08 | 2027-06-01 | ClinicalTrials.gov |
| NCT05504070 | Venclose digiRF System Post Market Study | Na | Venous Reflux | Active_Not_Recruiting | 2023-09-08 | 2027-06-01 | ClinicalTrials.gov |
| NCT05711316 | The BD Liverty™ TIPS Stent Graft Study | Na | Portal Hypertension | Active_Not_Recruiting | 2023-08-08 | 2027-01-11 | ClinicalTrials.gov |
| NCT05711316 | The BD Liverty™ TIPS Stent Graft Study | Na | Portal Hypertension | Active_Not_Recruiting | 2023-08-08 | 2027-01-11 | ClinicalTrials.gov |
| NCT05953363 | Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. | — | Anesthesia | Completed | 2023-07-24 | 2024-06-07 | ClinicalTrials.gov |
| NCT05953363 | Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. | — | Anesthesia | Completed | 2023-07-24 | 2024-06-07 | ClinicalTrials.gov |
| NCT05957406 | SMART TRENDS Study | Na | Moderate to High-risk Noncardiac Surgery | Completed | 2023-07-11 | 2025-10-27 | ClinicalTrials.gov |
| NCT05957406 | SMART TRENDS Study | Na | Moderate to High-risk Noncardiac Surgery | Completed | 2023-07-11 | 2025-10-27 | ClinicalTrials.gov |
| NCT05955560 | Male External Catheters' Comparison of Comfort and Efficacy | Na | Non-invasive Urine Output Management | Completed | 2023-06-12 | 2023-06-16 | ClinicalTrials.gov |
| NCT05955560 | Male External Catheters' Comparison of Comfort and Efficacy | Na | Non-invasive Urine Output Management | Completed | 2023-06-12 | 2023-06-16 | ClinicalTrials.gov |
| NCT05763147 | Study of BD Pre-filled Flush Syringes in China | Na | Effectiveness and Safety of Pre-filled Flush Syringe | Completed | 2022-11-03 | 2023-12-26 | ClinicalTrials.gov |
| NCT05763147 | Study of BD Pre-filled Flush Syringes in China | Na | Effectiveness and Safety of Pre-filled Flush Syringe | Completed | 2022-11-03 | 2023-12-26 | ClinicalTrials.gov |
| NCT05557422 | BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FA… | — | Chronic Lymphoproliferative Diseases (CLPD) | Completed | 2022-10-12 | 2024-05-08 | ClinicalTrials.gov |
| NCT05557422 | BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FA… | — | Chronic Lymphoproliferative Diseases (CLPD) | Completed | 2022-10-12 | 2024-05-08 | ClinicalTrials.gov |
| NCT05553418 | Investigational On-body Injector Clinical Study | Na | Healthy Volunteers | Completed | 2022-09-05 | 2023-02-08 | ClinicalTrials.gov |
| NCT05553418 | Investigational On-body Injector Clinical Study | Na | Healthy Volunteers | Completed | 2022-09-05 | 2023-02-08 | ClinicalTrials.gov |
| NCT05556681 | Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Art… | Na | Peripheral Arterial Disease | Completed | 2022-08-02 | 2025-11-24 | ClinicalTrials.gov |
| NCT05556681 | Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Art… | Na | Peripheral Arterial Disease | Completed | 2022-08-02 | 2025-11-24 | ClinicalTrials.gov |
| NCT05352581 | BD Veritor™ At-Home and BD Veritor™ Professional | — | Upper Respiratory Infection | Completed | 2022-07-21 | 2023-04-14 | ClinicalTrials.gov |
| NCT05352581 | BD Veritor™ At-Home and BD Veritor™ Professional | — | Upper Respiratory Infection | Completed | 2022-07-21 | 2023-04-14 | ClinicalTrials.gov |
| NCT05186311 | BD MiniDraw™ Capillary System Clinical Equivalence Study | — | Healthy | Completed | 2022-04-22 | 2022-10-24 | ClinicalTrials.gov |
| NCT05186311 | BD MiniDraw™ Capillary System Clinical Equivalence Study | — | Healthy | Completed | 2022-04-22 | 2022-10-24 | ClinicalTrials.gov |
| NCT05200546 | Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Manageme… | — | Multidrug-resistant Bacteria Screening | Completed | 2022-02-18 | 2023-03-31 | ClinicalTrials.gov |
| NCT05200546 | Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Manageme… | — | Multidrug-resistant Bacteria Screening | Completed | 2022-02-18 | 2023-03-31 | ClinicalTrials.gov |
| NCT05214560 | Prospective Clinical Evaluation of BD Spinal Needles | — | Analgesia | Completed | 2022-02-14 | 2022-07-22 | ClinicalTrials.gov |
| NCT05214560 | Prospective Clinical Evaluation of BD Spinal Needles | — | Analgesia | Completed | 2022-02-14 | 2022-07-22 | ClinicalTrials.gov |
| NCT05130762 | A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap… | Na | Catheter Related Complication | Completed | 2022-01-31 | 2023-05-22 | ClinicalTrials.gov |
| NCT05130762 | A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap… | Na | Catheter Related Complication | Completed | 2022-01-31 | 2023-05-22 | ClinicalTrials.gov |
| NCT05090722 | A Pilot Study to Evaluate PureWick for Nocturia | Na | Nocturia | Recruiting | 2021-12-16 | 2027-10-01 | ClinicalTrials.gov |
| NCT05090722 | A Pilot Study to Evaluate PureWick for Nocturia | Na | Nocturia | Recruiting | 2021-12-16 | 2027-10-01 | ClinicalTrials.gov |
| NCT04916067 | Stoma Closure and Reinforcement Trial ll | Na | Ileostomy - Stoma | Terminated | 2021-12-01 | 2024-08-05 | ClinicalTrials.gov |
| NCT04916067 | Stoma Closure and Reinforcement Trial ll | Na | Ileostomy - Stoma | Terminated | 2021-12-01 | 2024-08-05 | ClinicalTrials.gov |
| NCT05035615 | Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cyto… | — | Acute Leukemia | Completed | 2021-11-02 | 2024-07-18 | ClinicalTrials.gov |
| NCT05035615 | Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cyto… | — | Acute Leukemia | Completed | 2021-11-02 | 2024-07-18 | ClinicalTrials.gov |
| NCT05059808 | European Sepsis Care Survey | — | Sepsis | Completed | 2021-08-01 | 2022-10-30 | ClinicalTrials.gov |
| NCT05059808 | European Sepsis Care Survey | — | Sepsis | Completed | 2021-08-01 | 2022-10-30 | ClinicalTrials.gov |
| NCT04973085 | Neck Cooling as a Non-Invasive Method to Lower Brain Temperature in Healthy Adu… | Na | Healthy | Completed | 2021-07-22 | 2022-03-03 | ClinicalTrials.gov |
| NCT04973085 | Neck Cooling as a Non-Invasive Method to Lower Brain Temperature in Healthy Adu… | Na | Healthy | Completed | 2021-07-22 | 2022-03-03 | ClinicalTrials.gov |
| NCT04845906 | A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices | — | Peripheral Intravenous Catheter Stabilization | Completed | 2021-07-13 | 2021-08-23 | ClinicalTrials.gov |
| NCT04845906 | A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices | — | Peripheral Intravenous Catheter Stabilization | Completed | 2021-07-13 | 2021-08-23 | ClinicalTrials.gov |
| NCT04841330 | Prospective Healthy Volunteer Study of the Securis™ Stabilization Device | — | Peripheral Intavenous Catheter Stabilization | Completed | 2021-06-09 | 2021-07-20 | ClinicalTrials.gov |
| NCT04841330 | Prospective Healthy Volunteer Study of the Securis™ Stabilization Device | — | Peripheral Intavenous Catheter Stabilization | Completed | 2021-06-09 | 2021-07-20 | ClinicalTrials.gov |
| NCT04812327 | Capturing Infectious COVID-19 Asymptomatic Cases in Singapore | — | Covid19 | Withdrawn | 2021-06-01 | 2021-11-01 | ClinicalTrials.gov |
| NCT04812327 | Capturing Infectious COVID-19 Asymptomatic Cases in Singapore | — | Covid19 | Withdrawn | 2021-06-01 | 2021-11-01 | ClinicalTrials.gov |
| NCT05032339 | Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytomet… | — | Plasma Cell Disorder | Completed | 2021-05-04 | 2023-10-25 | ClinicalTrials.gov |
| NCT05032339 | Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytomet… | — | Plasma Cell Disorder | Completed | 2021-05-04 | 2023-10-25 | ClinicalTrials.gov |
| NCT05522153 | Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study | Phase1 | Blood Loss, Surgical | Completed | 2021-05-01 | 2023-06-08 | ClinicalTrials.gov |
| NCT05522153 | Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study | Phase1 | Blood Loss, Surgical | Completed | 2021-05-01 | 2023-06-08 | ClinicalTrials.gov |
| NCT04825418 | Beneficial Effect of Hypothermia Plus Hemicraniectomy Compared With Hemicraniec… | Na | Hypothermia | Unknown | 2021-05-01 | 2025-12-01 | ClinicalTrials.gov |
| NCT04825418 | Beneficial Effect of Hypothermia Plus Hemicraniectomy Compared With Hemicraniec… | Na | Hypothermia | Unknown | 2021-05-01 | 2025-12-01 | ClinicalTrials.gov |
| NCT05032313 | Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD … | — | Chronic Lymphoproliferative Diseases (CLPD) | Completed | 2021-04-26 | 2023-12-29 | ClinicalTrials.gov |
| NCT05032313 | Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD … | — | Chronic Lymphoproliferative Diseases (CLPD) | Completed | 2021-04-26 | 2023-12-29 | ClinicalTrials.gov |
| NCT04634916 | Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System | Na | Kidney Disease, End-Stage | Recruiting | 2021-03-26 | 2027-09-01 | ClinicalTrials.gov |
| NCT04634916 | Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System | Na | Kidney Disease, End-Stage | Recruiting | 2021-03-26 | 2027-09-01 | ClinicalTrials.gov |
| NCT04788849 | Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for H… | — | Cervical Intraepithelial Neoplasia Grade 2/3 | Completed | 2021-03-08 | 2021-07-31 | ClinicalTrials.gov |
| NCT04788849 | Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for H… | — | Cervical Intraepithelial Neoplasia Grade 2/3 | Completed | 2021-03-08 | 2021-07-31 | ClinicalTrials.gov |
| NCT04765566 | FLUENCY® PLUS in the Treatment of Peripheral Artery Disease | — | Vascular Diseases, Peripheral | Completed | 2021-02-05 | 2022-02-28 | ClinicalTrials.gov |
| NCT04765566 | FLUENCY® PLUS in the Treatment of Peripheral Artery Disease | — | Vascular Diseases, Peripheral | Completed | 2021-02-05 | 2022-02-28 | ClinicalTrials.gov |
| NCT04719377 | A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline… | Na | Catheterization | Completed | 2021-01-13 | 2022-01-30 | ClinicalTrials.gov |
| NCT04719377 | A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline… | Na | Catheterization | Completed | 2021-01-13 | 2022-01-30 | ClinicalTrials.gov |
| NCT04626427 | The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Invest… | Na | End Stage Kidney Disease | Terminated | 2020-12-23 | 2022-06-15 | ClinicalTrials.gov |
| NCT04626427 | The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Invest… | Na | End Stage Kidney Disease | Terminated | 2020-12-23 | 2022-06-15 | ClinicalTrials.gov |
| NCT04344314 | Impact of PIVC Length and Gauge on Catheter Indwell Time | Na | Indication for Peripheral Intravenous Catheterisation | Completed | 2020-08-31 | 2021-03-12 | ClinicalTrials.gov |
| NCT04344314 | Impact of PIVC Length and Gauge on Catheter Indwell Time | Na | Indication for Peripheral Intravenous Catheterisation | Completed | 2020-08-31 | 2021-03-12 | ClinicalTrials.gov |
| NCT04461678 | Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit | Na | Cervical Cancer | Completed | 2020-08-23 | 2024-08-26 | ClinicalTrials.gov |
| NCT04461678 | Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit | Na | Cervical Cancer | Completed | 2020-08-23 | 2024-08-26 | ClinicalTrials.gov |
| NCT04261686 | Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft | Na | Arteriovenous Fistula | Completed | 2020-07-03 | 2025-09-16 | ClinicalTrials.gov |
| NCT04261686 | Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft | Na | Arteriovenous Fistula | Completed | 2020-07-03 | 2025-09-16 | ClinicalTrials.gov |
| NCT04263649 | Prospective Observational Study of the Power PICC Family of Devices and Accesso… | — | Peripherally Inserted Central Catheter | Completed | 2020-06-18 | 2022-01-05 | ClinicalTrials.gov |
| NCT04263649 | Prospective Observational Study of the Power PICC Family of Devices and Accesso… | — | Peripherally Inserted Central Catheter | Completed | 2020-06-18 | 2022-01-05 | ClinicalTrials.gov |
| NCT04244370 | Caterpillar™ Arterial Embolization Device Post-Market Study | Na | Embolization, Therapeutic | Completed | 2020-04-30 | 2022-08-12 | ClinicalTrials.gov |
| NCT04244370 | Caterpillar™ Arterial Embolization Device Post-Market Study | Na | Embolization, Therapeutic | Completed | 2020-04-30 | 2022-08-12 | ClinicalTrials.gov |
| NCT04253756 | A Randomized Trial Examining Plasma Exchange Using the Becton Dickinson (BD) Ca… | Na | Plasma Exchange | Completed | 2020-03-31 | 2021-05-24 | ClinicalTrials.gov |
| NCT04253756 | A Randomized Trial Examining Plasma Exchange Using the Becton Dickinson (BD) Ca… | Na | Plasma Exchange | Completed | 2020-03-31 | 2021-05-24 | ClinicalTrials.gov |
| NCT04195854 | STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaff… | — | Plastic Surgery | Completed | 2019-12-17 | 2022-01-31 | ClinicalTrials.gov |
| NCT04195854 | STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaff… | — | Plastic Surgery | Completed | 2019-12-17 | 2022-01-31 | ClinicalTrials.gov |
| NCT03911700 | Prophylactic Reinforcement of Ventral Abdominal Incisions Trial | Na | Open Midline Laparotomy | Recruiting | 2019-12-12 | 2031-12-01 | ClinicalTrials.gov |
| NCT03911700 | Prophylactic Reinforcement of Ventral Abdominal Incisions Trial | Na | Open Midline Laparotomy | Recruiting | 2019-12-12 | 2031-12-01 | ClinicalTrials.gov |
| NCT04811430 | Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visu… | — | Catheter Related Complication | Completed | 2019-10-14 | 2019-10-15 | ClinicalTrials.gov |
| NCT04811430 | Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visu… | — | Catheter Related Complication | Completed | 2019-10-14 | 2019-10-15 | ClinicalTrials.gov |
| NCT04120974 | The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mel… | Na | Diabetes Mellitus, Type 2 | Completed | 2019-10-01 | 2021-04-26 | ClinicalTrials.gov |
| NCT04120974 | The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mel… | Na | Diabetes Mellitus, Type 2 | Completed | 2019-10-01 | 2021-04-26 | ClinicalTrials.gov |
| NCT04090320 | CATERPILLAR™ Arterial Embolization Device Study | Na | Embolization, Therapeutic | Completed | 2019-09-25 | 2020-11-04 | ClinicalTrials.gov |
| NCT04090320 | CATERPILLAR™ Arterial Embolization Device Study | Na | Embolization, Therapeutic | Completed | 2019-09-25 | 2020-11-04 | ClinicalTrials.gov |
| NCT04090242 | Impact of App Based Diabetes Training Program in Conjunction With the BD Nano P… | Na | Diabetes Mellitus, Type 2 | Terminated | 2019-09-06 | 2020-06-12 | ClinicalTrials.gov |
| NCT04090242 | Impact of App Based Diabetes Training Program in Conjunction With the BD Nano P… | Na | Diabetes Mellitus, Type 2 | Terminated | 2019-09-06 | 2020-06-12 | ClinicalTrials.gov |
| NCT04035161 | Evaluation of the Antimicrobial Effectiveness of CHG/IPA | — | Microbial Colonization | Completed | 2019-04-17 | 2019-12-24 | ClinicalTrials.gov |
| NCT04035161 | Evaluation of the Antimicrobial Effectiveness of CHG/IPA | — | Microbial Colonization | Completed | 2019-04-17 | 2019-12-24 | ClinicalTrials.gov |
| NCT03597009 | A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pl… | Phase1 | Malignant Pleural Effusion | Terminated | 2019-03-06 | 2020-02-12 | ClinicalTrials.gov |
| NCT03597009 | A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pl… | Phase1 | Malignant Pleural Effusion | Terminated | 2019-03-06 | 2020-02-12 | ClinicalTrials.gov |
| NCT03878745 | Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle v… | Na | Diabetes | Completed | 2019-02-11 | 2019-06-14 | ClinicalTrials.gov |
| NCT03878745 | Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle v… | Na | Diabetes | Completed | 2019-02-11 | 2019-06-14 | ClinicalTrials.gov |
| NCT03878758 | Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Ne… | Na | Diabetes | Completed | 2019-02-07 | 2019-04-30 | ClinicalTrials.gov |
| NCT03878758 | Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Ne… | Na | Diabetes | Completed | 2019-02-07 | 2019-04-30 | ClinicalTrials.gov |
| NCT03506308 | Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of … | Na | Arteriovenous Fistula | Active_Not_Recruiting | 2018-08-07 | 2030-04-01 | ClinicalTrials.gov |
| NCT03506308 | Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of … | Na | Arteriovenous Fistula | Active_Not_Recruiting | 2018-08-07 | 2030-04-01 | ClinicalTrials.gov |
| NCT04007003 | An Audit of the Impact of Tailored Information Delivered Via a Digital Learning… | Na | Diabetes Mellitus, Type 2 | Terminated | 2018-06-26 | 2019-08-10 | ClinicalTrials.gov |
| NCT04007003 | An Audit of the Impact of Tailored Information Delivered Via a Digital Learning… | Na | Diabetes Mellitus, Type 2 | Terminated | 2018-06-26 | 2019-08-10 | ClinicalTrials.gov |
| NCT04659330 | Lipohypertrophy Monitoring Study | Na | Diabetes Mellitus | Completed | 2018-06-01 | 2019-12-24 | ClinicalTrials.gov |
| NCT04659330 | Lipohypertrophy Monitoring Study | Na | Diabetes Mellitus | Completed | 2018-06-01 | 2019-12-24 | ClinicalTrials.gov |
| NCT03193619 | Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Fo… | — | Peripheral Arterial Disease | Completed | 2018-03-28 | 2022-04-01 | ClinicalTrials.gov |
| NCT03193619 | Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Fo… | — | Peripheral Arterial Disease | Completed | 2018-03-28 | 2022-04-01 | ClinicalTrials.gov |
| NCT02784730 | Iterative PICC Placement Versus Long Term Device | Phase3 | Breast Cancer | Withdrawn | 2018-01-10 | 2018-01-10 | ClinicalTrials.gov |
| NCT02784730 | Iterative PICC Placement Versus Long Term Device | Phase3 | Breast Cancer | Withdrawn | 2018-01-10 | 2018-01-10 | ClinicalTrials.gov |
| NCT03708562 | everlinQ Endovascular Access Systems Enhancements (EASE-2) Study | Na | Chronic Kidney Diseases | Completed | 2017-10-16 | 2018-12-12 | ClinicalTrials.gov |
| NCT03708562 | everlinQ Endovascular Access Systems Enhancements (EASE-2) Study | Na | Chronic Kidney Diseases | Completed | 2017-10-16 | 2018-12-12 | ClinicalTrials.gov |
| NCT03242005 | The PSIQS Study - User Experience With Pro-Set | Na | Diabetes Mellitus, Type 1 | Withdrawn | 2017-09-01 | 2018-02-01 | ClinicalTrials.gov |
| NCT03267264 | Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially … | Na | Diabetes | Completed | 2017-09-01 | 2018-05-24 | ClinicalTrials.gov |
| NCT03267264 | Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially … | Na | Diabetes | Completed | 2017-09-01 | 2018-05-24 | ClinicalTrials.gov |
| NCT03242005 | The PSIQS Study - User Experience With Pro-Set | Na | Diabetes Mellitus, Type 1 | Withdrawn | 2017-09-01 | 2018-02-01 | ClinicalTrials.gov |
| NCT03223415 | Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the I… | Na | Clostridium Difficile | Completed | 2017-08-25 | 2018-05-02 | ClinicalTrials.gov |
| NCT03223415 | Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the I… | Na | Clostridium Difficile | Completed | 2017-08-25 | 2018-05-02 | ClinicalTrials.gov |
| NCT03151928 | Diagnostic Accuracy By Providers Study | — | Vaginitis | Completed | 2017-07-06 | 2018-08-15 | ClinicalTrials.gov |
| NCT03151928 | Diagnostic Accuracy By Providers Study | — | Vaginitis | Completed | 2017-07-06 | 2018-08-15 | ClinicalTrials.gov |
| NCT03224299 | Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation | Phase2 | Preoperative Skin Preparation | Completed | 2017-06-21 | 2017-10-03 | ClinicalTrials.gov |
| NCT03224299 | Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation | Phase2 | Preoperative Skin Preparation | Completed | 2017-06-21 | 2017-10-03 | ClinicalTrials.gov |
| NCT03229759 | Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth | Phase2 | Preoperative Skin Preparation | Completed | 2017-06-21 | 2017-08-04 | ClinicalTrials.gov |
| NCT03229759 | Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth | Phase2 | Preoperative Skin Preparation | Completed | 2017-06-21 | 2017-08-04 | ClinicalTrials.gov |
| NCT03442803 | Propofol Target-Controlled Infusion in Emergency Department Sedation | Na | Shoulder Dislocation | Unknown | 2017-04-03 | 2018-12-31 | ClinicalTrials.gov |
| NCT03442803 | Propofol Target-Controlled Infusion in Emergency Department Sedation | Na | Shoulder Dislocation | Unknown | 2017-04-03 | 2018-12-31 | ClinicalTrials.gov |
| NCT03071146 | Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent Syst… | — | Peripheral Arterial Disease | Completed | 2017-02-15 | 2018-05-31 | ClinicalTrials.gov |
| NCT03071146 | Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent Syst… | — | Peripheral Arterial Disease | Completed | 2017-02-15 | 2018-05-31 | ClinicalTrials.gov |
| NCT02985060 | Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke | Phase2 | Ischemic Stroke | Unknown | 2016-11-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT02985060 | Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke | Phase2 | Ischemic Stroke | Unknown | 2016-11-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT03020121 | Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples | Na | Uterine Cervical Neoplasm | Terminated | 2016-11-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT03020121 | Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples | Na | Uterine Cervical Neoplasm | Terminated | 2016-11-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02682420 | everlinQ endoAVF Post Market Study | Na | Chronic Kidney Disease | Terminated | 2016-09-20 | 2019-08-01 | ClinicalTrials.gov |
| NCT02682420 | everlinQ endoAVF Post Market Study | Na | Chronic Kidney Disease | Terminated | 2016-09-20 | 2019-08-01 | ClinicalTrials.gov |
| NCT02847546 | Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic … | — | Aortic Valve Stenosis | Completed | 2016-09-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02847546 | Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic … | — | Aortic Valve Stenosis | Completed | 2016-09-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02746159 | Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treat… | — | Arteriovenous Fistula | Completed | 2016-06-07 | 2019-03-09 | ClinicalTrials.gov |
| NCT02746159 | Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treat… | — | Arteriovenous Fistula | Completed | 2016-06-07 | 2019-03-09 | ClinicalTrials.gov |
| NCT02649946 | Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft | Na | Stenosis | Completed | 2016-06-01 | 2021-02-01 | ClinicalTrials.gov |
| NCT02649946 | Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft | Na | Stenosis | Completed | 2016-06-01 | 2021-02-01 | ClinicalTrials.gov |
| NCT04569565 | Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory As… | Na | Ascites Hepatic | Completed | 2016-05-18 | 2019-03-20 | ClinicalTrials.gov |
| NCT04569565 | Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory As… | Na | Ascites Hepatic | Completed | 2016-05-18 | 2019-03-20 | ClinicalTrials.gov |
| NCT02691962 | Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias | Na | Incisional Hernia | Completed | 2016-05-01 | 2020-05-01 | ClinicalTrials.gov |
| NCT02887261 | Study on Indications of "Bard" PowerPort Isp Implantable Port | Na | Power Port | Completed | 2016-05-01 | 2019-05-31 | ClinicalTrials.gov |
| NCT02649894 | Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, … | Na | Malignant Pleural Effusion | Completed | 2016-05-01 | 2018-04-18 | ClinicalTrials.gov |
| NCT02887261 | Study on Indications of "Bard" PowerPort Isp Implantable Port | Na | Power Port | Completed | 2016-05-01 | 2019-05-31 | ClinicalTrials.gov |
| NCT02691962 | Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias | Na | Incisional Hernia | Completed | 2016-05-01 | 2020-05-01 | ClinicalTrials.gov |
| NCT02649894 | Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, … | Na | Malignant Pleural Effusion | Completed | 2016-05-01 | 2018-04-18 | ClinicalTrials.gov |
| NCT02720003 | A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) fo… | Na | Femoral Artery Stenosis | Completed | 2016-03-01 | 2020-08-01 | ClinicalTrials.gov |
| NCT02720003 | A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) fo… | Na | Femoral Artery Stenosis | Completed | 2016-03-01 | 2020-08-01 | ClinicalTrials.gov |
| NCT02662842 | BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study | — | Type 1 Diabetes Mellitus | Completed | 2016-01-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02662842 | BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study | — | Type 1 Diabetes Mellitus | Completed | 2016-01-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02717104 | Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutoni… | — | Peripheral Artery Disease | Completed | 2015-08-20 | 2020-06-01 | ClinicalTrials.gov |
| NCT02717104 | Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutoni… | — | Peripheral Artery Disease | Completed | 2015-08-20 | 2020-06-01 | ClinicalTrials.gov |
| NCT02517749 | Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural E… | Na | Pleural Effusion, Malignant | Completed | 2015-08-01 | 2020-03-01 | ClinicalTrials.gov |
| NCT02517749 | Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural E… | Na | Pleural Effusion, Malignant | Completed | 2015-08-01 | 2020-03-01 | ClinicalTrials.gov |
| NCT03708770 | everlinQ Endovascular Access System Enhancements (EASE) Study | Na | Chronic Kidney Diseases | Completed | 2015-07-27 | 2017-06-19 | ClinicalTrials.gov |
| NCT03708770 | everlinQ Endovascular Access System Enhancements (EASE) Study | Na | Chronic Kidney Diseases | Completed | 2015-07-27 | 2017-06-19 | ClinicalTrials.gov |
| NCT02498821 | Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation | Na | Indication for PICC Placement | Completed | 2015-05-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02498821 | Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation | Na | Indication for PICC Placement | Completed | 2015-05-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02424383 | Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated B… | Na | Peripheral Arterial Disease | Completed | 2015-04-23 | 2019-10-21 | ClinicalTrials.gov |
| NCT02424383 | Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated B… | Na | Peripheral Arterial Disease | Completed | 2015-04-23 | 2019-10-21 | ClinicalTrials.gov |
| NCT02449798 | Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Di… | Na | Vascular Access Complication | Completed | 2015-03-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02449798 | Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Di… | Na | Vascular Access Complication | Completed | 2015-03-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02396355 | Accuracy Evaluation of the BD FACS Presto System | — | Acquired Immunodeficiency Syndrome | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02396355 | Accuracy Evaluation of the BD FACS Presto System | — | Acquired Immunodeficiency Syndrome | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02271594 | Treating Diabetic Lipohypertrophy With Intensive Education Versus Standard Care | Na | Insulin Injections and Lipohypertrophy | Terminated | 2015-01-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02271594 | Treating Diabetic Lipohypertrophy With Intensive Education Versus Standard Care | Na | Insulin Injections and Lipohypertrophy | Terminated | 2015-01-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02657226 | Intensive Monitoring of Renal Function | — | Intensive Monitoring of Renal Function | Completed | 2015-01-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02657226 | Intensive Monitoring of Renal Function | — | Intensive Monitoring of Renal Function | Completed | 2015-01-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02267876 | Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System Wit… | — | Cervical Neoplasms | Completed | 2014-10-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT02278991 | Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal… | — | Peripheral Artery Disease | Completed | 2014-10-01 | 2018-10-02 | ClinicalTrials.gov |
| NCT02267876 | Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System Wit… | — | Cervical Neoplasms | Completed | 2014-10-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT02278991 | Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal… | — | Peripheral Artery Disease | Completed | 2014-10-01 | 2018-10-02 | ClinicalTrials.gov |
| NCT02262949 | A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System | Na | Peripheral Artery Disease | Completed | 2014-09-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02262949 | A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System | Na | Peripheral Artery Disease | Completed | 2014-09-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02228564 | BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arte… | Na | Peripheral Artery Disease | Completed | 2014-09-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT02228564 | BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arte… | Na | Peripheral Artery Disease | Completed | 2014-09-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT02382536 | Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults | — | Diabetes | Completed | 2014-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02382536 | Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults | — | Diabetes | Completed | 2014-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02186522 | Immune Failure in Critical Therapy (INFECT) Study | — | Sepsis | Completed | 2014-07-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02186522 | Immune Failure in Critical Therapy (INFECT) Study | — | Sepsis | Completed | 2014-07-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02227732 | A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter… | Na | Malignant Pleural Effusions | Completed | 2014-04-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02227732 | A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter… | Na | Malignant Pleural Effusions | Completed | 2014-04-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02063672 | Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of … | Na | Femoral Artery Stenosis | Completed | 2014-03-01 | 2019-03-01 | ClinicalTrials.gov |
| NCT02063672 | Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of … | Na | Femoral Artery Stenosis | Completed | 2014-03-01 | 2019-03-01 | ClinicalTrials.gov |
| NCT02053168 | A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incis… | Na | Ventral Hernia | Completed | 2014-02-01 | 2017-02-23 | ClinicalTrials.gov |
| NCT02792764 | Post-Marketing Study to Assess Complication Rates of Oncology Patients With Por… | — | PORTs/Peripheral IVs Complication Rates | Completed | 2014-02-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02792764 | Post-Marketing Study to Assess Complication Rates of Oncology Patients With Por… | — | PORTs/Peripheral IVs Complication Rates | Completed | 2014-02-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02053168 | A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incis… | Na | Ventral Hernia | Completed | 2014-02-01 | 2017-02-23 | ClinicalTrials.gov |
| NCT02043951 | Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the … | — | Peripheral Artery Disease | Terminated | 2014-01-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02188992 | Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study | — | Sepsis | Completed | 2014-01-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02036671 | Novel Endovascular Access Trial (NEAT) | Na | Chronic Kidney Disease | Completed | 2014-01-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02036671 | Novel Endovascular Access Trial (NEAT) | Na | Chronic Kidney Disease | Completed | 2014-01-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02043951 | Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the … | — | Peripheral Artery Disease | Terminated | 2014-01-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02188992 | Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study | — | Sepsis | Completed | 2014-01-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT03028090 | Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of… | — | Indication for Peripheral Intravenous Catheterization | Completed | 2013-11-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01959503 | Progel Vascular Sealant | Na | Aortic Valve Stenosis | Completed | 2013-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01959503 | Progel Vascular Sealant | Na | Aortic Valve Stenosis | Completed | 2013-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT03028090 | Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of… | — | Indication for Peripheral Intravenous Catheterization | Completed | 2013-11-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01961687 | A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Her… | Na | Ventral Hernia | Completed | 2013-09-01 | 2020-01-27 | ClinicalTrials.gov |
| NCT01961687 | A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Her… | Na | Ventral Hernia | Completed | 2013-09-01 | 2020-01-27 | ClinicalTrials.gov |
| NCT01940354 | Comparison of AccuCath IV Catheter and Conventional IV Catheter in Intervention… | Na | Vascular Access Complications | Completed | 2013-08-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01940354 | Comparison of AccuCath IV Catheter and Conventional IV Catheter in Intervention… | Na | Vascular Access Complications | Completed | 2013-08-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01920308 | A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent S… | — | Peripheral Artery Disease | Completed | 2013-08-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01920308 | A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent S… | — | Peripheral Artery Disease | Completed | 2013-08-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01944722 | Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System W… | Na | Uterine Cervical Neoplasms | Completed | 2013-08-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01944722 | Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System W… | Na | Uterine Cervical Neoplasms | Completed | 2013-08-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01870401 | Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee… | Na | Critical Limb Ischemia | Completed | 2013-06-03 | 2021-06-22 | ClinicalTrials.gov |
| NCT01870401 | Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee… | Na | Critical Limb Ischemia | Completed | 2013-06-03 | 2021-06-22 | ClinicalTrials.gov |
| NCT01867658 | Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracosc… | Na | Pulmonary Disease | Completed | 2013-06-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01867658 | Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracosc… | Na | Pulmonary Disease | Completed | 2013-06-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01841242 | Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for I… | Phase4 | Heart Failure | Completed | 2013-04-23 | 2021-01-31 | ClinicalTrials.gov |
| NCT01841242 | Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for I… | Phase4 | Heart Failure | Completed | 2013-04-23 | 2021-01-31 | ClinicalTrials.gov |
| NCT02119832 | A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Dev… | Na | Chronic Kidney Disease (CKD) | Completed | 2013-04-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01937195 | AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT) | Na | Vascular Access Complication | Completed | 2013-04-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01943474 | AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In G… | Na | Vascular Access Complication | Completed | 2013-04-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01937195 | AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT) | Na | Vascular Access Complication | Completed | 2013-04-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01943474 | AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In G… | Na | Vascular Access Complication | Completed | 2013-04-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT02119832 | A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Dev… | Na | Chronic Kidney Disease (CKD) | Completed | 2013-04-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01816412 | LEVANT Japan Clinical Trial | Phase2 | Femoral Arterial Stenosis | Completed | 2013-03-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01816412 | LEVANT Japan Clinical Trial | Phase2 | Femoral Arterial Stenosis | Completed | 2013-03-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02786173 | Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" | — | Peripheral Arterial Disease | Completed | 2013-01-01 | 2021-11-05 | ClinicalTrials.gov |
| NCT01772550 | Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Con… | Na | Contrast Enhanced Computed Tomography | Completed | 2013-01-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT02786173 | Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" | — | Peripheral Arterial Disease | Completed | 2013-01-01 | 2021-11-05 | ClinicalTrials.gov |
| NCT01772550 | Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Con… | Na | Contrast Enhanced Computed Tomography | Completed | 2013-01-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01864278 | Lutonix Global SFA Registry | — | Peripheral Artery Disease | Completed | 2012-12-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01746550 | A Safety and Effectiveness Study of the MD-12-001 Stent in the Treatment of Sup… | Na | Arterial Occlusive Disease | Completed | 2012-12-01 | 2018-10-01 | ClinicalTrials.gov |
| NCT01864278 | Lutonix Global SFA Registry | — | Peripheral Artery Disease | Completed | 2012-12-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01746550 | A Safety and Effectiveness Study of the MD-12-001 Stent in the Treatment of Sup… | Na | Arterial Occlusive Disease | Completed | 2012-12-01 | 2018-10-01 | ClinicalTrials.gov |
| NCT01852136 | Clinical Evaluation of BD NEXT Pen Needle | — | Diabetes Mellitus, Type 2 | Completed | 2012-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01852136 | Clinical Evaluation of BD NEXT Pen Needle | — | Diabetes Mellitus, Type 2 | Completed | 2012-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT02119845 | A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Dev… | Na | Chronic Kidney Disease (CKD) | Completed | 2012-08-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01524705 | FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) | Phase4 | Type 2 Diabetes | Completed | 2012-08-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01671462 | European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System | — | Uterine Cervical Neoplasms | Completed | 2012-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01524705 | FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) | Phase4 | Type 2 Diabetes | Completed | 2012-08-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01671462 | European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System | — | Uterine Cervical Neoplasms | Completed | 2012-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT02119845 | A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Dev… | Na | Chronic Kidney Disease (CKD) | Completed | 2012-08-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01645696 | Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sen… | Na | Diabetes | Completed | 2012-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01628159 | LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB) | Na | Peripheral Artery Disease | Completed | 2012-06-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT01645696 | Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sen… | Na | Diabetes | Completed | 2012-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01628159 | LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB) | Na | Peripheral Artery Disease | Completed | 2012-06-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT01557907 | Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal an… | Phase1 | Diabetes | Completed | 2012-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01557907 | Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal an… | Phase1 | Diabetes | Completed | 2012-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01469715 | A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continu… | Phase2 | Type 1 Diabetes Mellitus | Completed | 2011-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01469715 | A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continu… | Phase2 | Type 1 Diabetes Mellitus | Completed | 2011-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01482793 | A Controlled Trial of Vertebroplasty for Acute Painful Osteoporotic Fractures | Na | Vertebral Compression Fractures | Completed | 2011-11-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02053831 | GalaFlex Mesh in Facelift | — | Superficial Musculoaponeurotic System (SMAS) Procedure | Completed | 2011-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01482793 | A Controlled Trial of Vertebroplasty for Acute Painful Osteoporotic Fractures | Na | Vertebral Compression Fractures | Completed | 2011-11-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02053831 | GalaFlex Mesh in Facelift | — | Superficial Musculoaponeurotic System (SMAS) Procedure | Completed | 2011-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01413555 | Multicenter Blood Culture Quality Improvement | Na | Bacteremia | Completed | 2011-08-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01413555 | Multicenter Blood Culture Quality Improvement | Na | Bacteremia | Completed | 2011-08-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01790243 | LEVANT 2 Safety Registry | Na | Peripheral Artery Disease | Completed | 2011-07-20 | 2018-11-01 | ClinicalTrials.gov |
| NCT01790243 | LEVANT 2 Safety Registry | Na | Peripheral Artery Disease | Completed | 2011-07-20 | 2018-11-01 | ClinicalTrials.gov |
| NCT01394978 | NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study | Na | Lung Cancer | Completed | 2011-06-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01394978 | NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study | Na | Lung Cancer | Completed | 2011-06-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01366417 | Topical Antimicrobial Effectiveness Testing | Phase4 | Antimicrobial Effectiveness | Completed | 2011-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01366417 | Topical Antimicrobial Effectiveness Testing | Phase4 | Antimicrobial Effectiveness | Completed | 2011-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01334606 | Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 4… | Na | Diabetes Mellitus, Type 2 | Terminated | 2011-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01334606 | Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 4… | Na | Diabetes Mellitus, Type 2 | Terminated | 2011-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01314703 | Topical Antimicrobial Effectiveness Testing | Phase4 | Antimicrobial Effectiveness | Completed | 2011-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01314703 | Topical Antimicrobial Effectiveness Testing | Phase4 | Antimicrobial Effectiveness | Completed | 2011-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00908947 | CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent Sy… | Na | Superficial Femoral Artery Stenosis | Terminated | 2011-02-01 | 2018-09-19 | ClinicalTrials.gov |
| NCT00908947 | CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent Sy… | Na | Superficial Femoral Artery Stenosis | Terminated | 2011-02-01 | 2018-09-19 | ClinicalTrials.gov |
| NCT01275430 | Assessment of the Precision of the Sherlock 3CG Tip Positioning System | Na | No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement | Terminated | 2011-01-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01290796 | Clinical Evaluation of Ajust™ in Stress Urinary Incontinence | Na | Female Stress Urinary Incontinence | Completed | 2011-01-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01275430 | Assessment of the Precision of the Sherlock 3CG Tip Positioning System | Na | No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement | Terminated | 2011-01-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01290796 | Clinical Evaluation of Ajust™ in Stress Urinary Incontinence | Na | Female Stress Urinary Incontinence | Completed | 2011-01-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01257438 | FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis | Na | Restenosis | Completed | 2010-12-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01257438 | FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis | Na | Restenosis | Completed | 2010-12-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01231984 | Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Nee… | Na | Diabetes Mellitus, Type 1 | Completed | 2010-10-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01231984 | Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Nee… | Na | Diabetes Mellitus, Type 1 | Completed | 2010-10-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01234480 | Intended Use Study of the BD SurePath Plus™ Pap | — | Uterine Cervical Neoplasms | Terminated | 2010-09-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01205399 | A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repa… | — | Hernia | Completed | 2010-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01234480 | Intended Use Study of the BD SurePath Plus™ Pap | — | Uterine Cervical Neoplasms | Terminated | 2010-09-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01205399 | A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repa… | — | Hernia | Completed | 2010-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01179984 | Bard® LifeStent® Vascular Stent Delivery System Study | Na | Peripheral Vascular Disease | Completed | 2010-06-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01179984 | Bard® LifeStent® Vascular Stent Delivery System Study | Na | Peripheral Vascular Disease | Completed | 2010-06-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01120444 | Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Do… | Phase1 | Diabetes | Completed | 2010-04-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01112020 | Components of Chlorhexidine Gluconate Dressing | Phase1 | Healthy | Completed | 2010-04-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01120444 | Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Do… | Phase1 | Diabetes | Completed | 2010-04-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01112020 | Components of Chlorhexidine Gluconate Dressing | Phase1 | Healthy | Completed | 2010-04-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01205386 | Crosser Enters The Right Arterial Lumen | — | Chronic Total Occlusion of Artery of the Extremities | Completed | 2010-02-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01205386 | Crosser Enters The Right Arterial Lumen | — | Chronic Total Occlusion of Artery of the Extremities | Completed | 2010-02-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01061216 | Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered E… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2010-01-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01061216 | Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered E… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2010-01-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01372917 | Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study | — | Malignant Neoplasm of the Breast | Completed | 2010-01-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01372917 | Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study | — | Malignant Neoplasm of the Breast | Completed | 2010-01-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01072838 | Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radi… | Phase2 | Breast Cancer | Terminated | 2009-12-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01072838 | Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radi… | Phase2 | Breast Cancer | Terminated | 2009-12-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT00978939 | Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwell… | Phase4 | Pleural Effusion, Malignant | Completed | 2009-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00978939 | Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwell… | Phase4 | Pleural Effusion, Malignant | Completed | 2009-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00934752 | De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting f… | Phase1 | Coronary Artery Stenosis | Completed | 2009-07-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00934752 | De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting f… | Phase1 | Coronary Artery Stenosis | Completed | 2009-07-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00928057 | Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles | Na | Diabetes Mellitus, Type 1 | Completed | 2009-06-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00930813 | LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropop… | Phase1 | Atherosclerosis | Completed | 2009-06-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00928057 | Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles | Na | Diabetes Mellitus, Type 1 | Completed | 2009-06-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00914069 | Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventiona… | Na | Vascular Access Complication | Terminated | 2009-06-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT00914069 | Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventiona… | Na | Vascular Access Complication | Terminated | 2009-06-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT00930813 | LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropop… | Phase1 | Atherosclerosis | Completed | 2009-06-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00866814 | Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch | — | Ventral Hernia | Completed | 2009-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00866814 | Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch | — | Ventral Hernia | Completed | 2009-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01093833 | A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal a… | Phase1 | Diabetes | Completed | 2009-01-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT01093833 | A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal a… | Phase1 | Diabetes | Completed | 2009-01-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00677235 | Post-Approval Study for the FLAIR Endovascular Stent Graft | Na | Stenosis of Vascular Prosthetic Devices, Implants and Grafts | Completed | 2008-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT00677235 | Post-Approval Study for the FLAIR Endovascular Stent Graft | Na | Stenosis of Vascular Prosthetic Devices, Implants and Grafts | Completed | 2008-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT00761618 | Intrapleural Catheter Daily Versus Three Times a Week Drainage | Phase2 | Advanced Cancer | Active_Not_Recruiting | 2008-08-22 | 2026-08-31 | ClinicalTrials.gov |
| NCT00761618 | Intrapleural Catheter Daily Versus Three Times a Week Drainage | Phase2 | Advanced Cancer | Active_Not_Recruiting | 2008-08-22 | 2026-08-31 | ClinicalTrials.gov |
| NCT00741390 | Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of … | Na | Diabetes Mellitus, Type 1 | Completed | 2008-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00741390 | Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of … | Na | Diabetes Mellitus, Type 1 | Completed | 2008-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00742053 | Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Pl… | Na | Primary Focus: Adult Subjects Who Require PICC Placement | Terminated | 2008-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00742053 | Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Pl… | Na | Primary Focus: Adult Subjects Who Require PICC Placement | Terminated | 2008-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00679848 | Transoral Gastric Volume Reduction as an Intervention for Weight Management | Phase1 | Obesity | Completed | 2008-05-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00679848 | Transoral Gastric Volume Reduction as an Intervention for Weight Management | Phase1 | Obesity | Completed | 2008-05-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00667381 | Femoral Arterial Access With Ultrasound Trial | Na | Vascular Access Complications | Completed | 2008-04-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00667381 | Femoral Arterial Access With Ultrasound Trial | Na | Vascular Access Complications | Completed | 2008-04-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00573105 | Laparoscopic Ventral Hernia Repair by Heavy Weight or Lighter Weight Mesh (COMP… | Na | Ventral Hernia | Terminated | 2008-02-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00573105 | Laparoscopic Ventral Hernia Repair by Heavy Weight or Lighter Weight Mesh (COMP… | Na | Ventral Hernia | Terminated | 2008-02-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00614315 | FLAIR™ Delivery System Study | Na | Constriction, Pathologic | Completed | 2007-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00614315 | FLAIR™ Delivery System Study | Na | Constriction, Pathologic | Completed | 2007-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00692484 | Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2… | Phase3 | Healthy | Completed | 2007-10-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00692484 | Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2… | Phase3 | Healthy | Completed | 2007-10-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00553488 | Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Gluc… | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2007-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00553488 | Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Gluc… | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2007-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00482547 | Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS) | Phase4 | Catheterization | Terminated | 2007-06-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00482547 | Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS) | Phase4 | Catheterization | Terminated | 2007-06-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00394212 | Incisionless Treatment for Patients With Inadequate Weight Loss Following Roux-… | Phase3 | Obesity | Terminated | 2006-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00394212 | Incisionless Treatment for Patients With Inadequate Weight Loss Following Roux-… | Phase3 | Obesity | Terminated | 2006-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00293943 | Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… | Na | Atrial Fibrillation | Completed | 2006-02-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00293943 | Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… | Na | Atrial Fibrillation | Completed | 2006-02-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00556426 | Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval o… | Na | Pulmonary Embolism | Completed | 2005-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00556426 | Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval o… | Na | Pulmonary Embolism | Completed | 2005-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00265629 | RF Ablation of Atrial Fibrillation | Phase1 | Atrial Fibrillation | Completed | 2005-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00265629 | RF Ablation of Atrial Fibrillation | Phase1 | Atrial Fibrillation | Completed | 2005-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00289588 | An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Au… | Na | Community-Acquired MRSA Infections | Completed | 2005-01-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00289588 | An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Au… | Na | Community-Acquired MRSA Infections | Completed | 2005-01-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00706693 | Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabet… | Na | Type 1 Diabetes Mellitus | Completed | 2003-08-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00706693 | Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabet… | Na | Type 1 Diabetes Mellitus | Completed | 2003-08-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00561457 | A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System | Na | Iliac Artery Occlusive Disease | Completed | 2003-06-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00561457 | A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System | Na | Iliac Artery Occlusive Disease | Completed | 2003-06-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00148642 | Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP) | Phase3 | Respiratory Failure | Completed | 2002-11-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00148642 | Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP) | Phase3 | Respiratory Failure | Completed | 2002-11-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00434382 | Neuronal Mechanisms of Sensory Processing During General Anesthesia | Na | General Anesthesia | Unknown | 2002-10-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00434382 | Neuronal Mechanisms of Sensory Processing During General Anesthesia | Na | General Anesthesia | Unknown | 2002-10-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01057550 | Randomised Controlled Trial Comparing Tension-Free Vaginal Tape (TVT), Pelvicol… | Phase3 | Stress Urinary Incontinence | Completed | 2001-10-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01057550 | Randomised Controlled Trial Comparing Tension-Free Vaginal Tape (TVT), Pelvicol… | Phase3 | Stress Urinary Incontinence | Completed | 2001-10-01 | 2006-11-01 | ClinicalTrials.gov |
Total clinical trials: 382
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Temperature Control | Other | Approved | Cardiac Arrest (CA) | NOT_YET_RECRUITING | NCT07769086 |
| Head Positioning | Other | Approved | Cardiac Arrest (CA) | NOT_YET_RECRUITING | NCT07769086 |
| EndoAVF Creation | Other | Approved | Kidney Disease, End-Stage | RECRUITING | NCT04634916 |
| UltraFlex Self-Adhering Male External Catheter | Other | Approved | Urinary Incontinence | COMPLETED | NCT07282860 |
| PureWick System | Other | Approved | Urinary Incontinence | COMPLETED | NCT07282860 |
| External Urinary Catheter | Other | Preclinical | Urine Output | NOT_YET_RECRUITING | NCT07744945 |
| Indwelling Urinary Catheter | Other | Preclinical | Urine Output | NOT_YET_RECRUITING | NCT07744945 |
| BD Liverty™ TIPS Stent Graft | Other | Approved | Portal Hypertension | ACTIVE_NOT_RECRUITING | NCT05711316 |
| BD Liverty™ TIPS Stent Graft | Other | Approved | Portal Hypertension | ACTIVE_NOT_RECRUITING | NCT05711316 |
| HemoSphere Vita Monitor with VitaWave or VitaWave Plus Finger Cuff Adult, and ForeSight Large Sensors | Other | Approved | Blood Pressure | RECRUITING | NCT07216573 |
| ClearSight NextGen system | Other | Approved | Blood Pressure | COMPLETED | NCT07317648 |
| HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring | Other | Approved | Blood Pressure | RECRUITING | NCT06492746 |
| The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff | Other | Approved | Moderate to High-risk Noncardiac Surgery | COMPLETED | NCT05957406 |
| Acumen HPI Smart Alerts and Smart Trends Software | Other | Approved | Moderate to High-risk Noncardiac Surgery | COMPLETED | NCT05957406 |
| HemoSphere Alta Monitor, Swan-Ganz IQ pulmonary arterial catheter, ForeSight IQ Large sensor, and Acumen IQ sensor | Other | Preclinical | Hemodynamic Instability | ACTIVE_NOT_RECRUITING | NCT07148323 |
| PureWick System | Other | Approved | Nocturia | RECRUITING | NCT05090722 |
| Phasix™ Mesh | Other | Approved | Open Midline Laparotomy | RECRUITING | NCT03911700 |
| Arm A - Application of 5g of ARISTA™ AH | Other | Approved | Prostate Cancer (Adenocarcinoma) | RECRUITING | NCT06822036 |
| Standard surgery | Procedure | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| GalaFLEX LITE™ Scaffold | Other | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| Standard surgery | Procedure | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| GalaFLEX LITE™ Scaffold | Other | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| Standard surgery | Procedure | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| GalaFLEX LITE™ Scaffold | Other | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| Standard surgery | Procedure | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| GalaFLEX LITE™ Scaffold | Other | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| Standard surgery | Procedure | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| GalaFLEX LITE™ Scaffold | Other | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| Ingestion of Fruit to Go (TM) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT00706693 |
| Ingestion of Skittles (TM) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT00706693 |
| Ingestion of BD glucose tablets (TM) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT00706693 |
| Ingestion of Fruit to Go (TM) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT00706693 |
| Ingestion of Skittles (TM) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT00706693 |
| Ingestion of BD glucose tablets (TM) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT00706693 |
| Insulin lispro (Humalog) | Other | Phase PHASE2 | Diabetes Mellitus, Type 1 | COMPLETED | NCT00553488 |
| Regular insulin (Humulin) | Other | Phase PHASE2 | Diabetes Mellitus, Type 1 | COMPLETED | NCT00553488 |
| Insulin lispro (Humalog) | Other | Phase PHASE2 | Diabetes Mellitus, Type 1 | COMPLETED | NCT00553488 |
| Regular insulin (Humulin) | Other | Phase PHASE2 | Diabetes Mellitus, Type 1 | COMPLETED | NCT00553488 |
| Pelvicol | Other | Phase PHASE3 | Stress Urinary Incontinence | COMPLETED | NCT01057550 |
| TVT | Other | Phase PHASE3 | Stress Urinary Incontinence | COMPLETED | NCT01057550 |
| Autologous fascial sling | Other | Phase PHASE3 | Stress Urinary Incontinence | COMPLETED | NCT01057550 |
| Subcutaneous insulin delivery:ACCU-CHEK Rapid-D Infusion Set | Other | Phase PHASE1 | Diabetes Mellitus, Type 1 | COMPLETED | NCT01061216 |
| Intradermal insulin delivery: BD Research Catheter Set | Other | Phase PHASE1 | Diabetes Mellitus, Type 1 | COMPLETED | NCT01061216 |
| OTM/28G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| ACC/28G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| OTU/28G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| OTM / 33G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| BD/33G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| OTM/28G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| ACC/28G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| OTU/28G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| OTM / 33G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| BD/33G | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00741390 |
| Midlatency auditory evoked potentials | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Remifentanil | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Alfentanil | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Sufentanil | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Fentanyl | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Propofol | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Desflurane | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Isoflurane | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| Sevoflurane | Other | Approved | General Anesthesia | UNKNOWN | NCT00434382 |
| 5mm x 31G pen needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00928057 |
| 8mm x 31G pen needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00928057 |
| 4mm x 32G pen needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00928057 |
| 5mm x 31G pen needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00928057 |
| 8mm x 31G pen needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00928057 |
| 4mm x 32G pen needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT00928057 |
| Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine) | Other | Approved | Vascular Access Complications | COMPLETED | NCT00667381 |
| Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine) | Other | Approved | Vascular Access Complications | COMPLETED | NCT00667381 |
| Laparoscopic Ventral hernia repair by lighter weight mesh | Other | Approved | Ventral Hernia | TERMINATED | NCT00573105 |
| Laparoscopic Ventral hernia repair by heavy weight mesh | Other | Approved | Ventral Hernia | TERMINATED | NCT00573105 |
| Subcutaneous delivery of insulin using Disetronic Accu-Chek Rapid D infusion set | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01120444 |
| BD Research Catheter with 34G x 1.5 mm needle | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01120444 |
| Subcutaneous delivery of insulin using Disetronic Accu-Chek Rapid D infusion set | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01120444 |
| BD Research Catheter with 34G x 1.5 mm needle | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01120444 |
| Bard Recovery G2 Filter System | Other | Approved | Pulmonary Embolism | COMPLETED | NCT00556426 |
| Intradermal delivery via the BD Research Catheter Set | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01557907 |
| Subcutaneous delivery via Medtronic Quick-Set | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01557907 |
| Bard Ventrio Hernia Patch | Other | Preclinical | Ventral Hernia | COMPLETED | NCT00866814 |
| Contura MLB Breast Brachytherapy Catheter | Drug | Phase PHASE2 | Breast Cancer | TERMINATED | NCT01072838 |
| APBI (Dose Escalation) | Other | Phase PHASE2 | Breast Cancer | TERMINATED | NCT01072838 |
| Aggressive Drainage Instructions | Other | Phase PHASE4 | Pleural Effusion, Malignant | COMPLETED | NCT00978939 |
| Standard Drainage Instructions | Other | Phase PHASE4 | Pleural Effusion, Malignant | COMPLETED | NCT00978939 |
| 18GA Conventional Catheter | Other | Approved | Contrast Enhanced Computed Tomography | COMPLETED | NCT01772550 |
| 20GA BD Nexiva Diffusics | Other | Approved | Contrast Enhanced Computed Tomography | COMPLETED | NCT01772550 |
| 18GA Conventional Catheter | Other | Approved | Contrast Enhanced Computed Tomography | COMPLETED | NCT01772550 |
| 20GA BD Nexiva Diffusics | Other | Approved | Contrast Enhanced Computed Tomography | COMPLETED | NCT01772550 |
| RF catheter ablation | Other | Phase PHASE1 | Atrial Fibrillation | COMPLETED | NCT00265629 |
| 1. CROSSER System | Other | Preclinical | Chronic Total Occlusion of Artery of the Extremities | COMPLETED | NCT01205386 |
| 1. CROSSER System | Other | Preclinical | Chronic Total Occlusion of Artery of the Extremities | COMPLETED | NCT01205386 |
| BD HPV assay on Viper LT | Other | Preclinical | Uterine Cervical Neoplasms | COMPLETED | NCT01671462 |
| BD HPV assay on Viper LT | Other | Preclinical | Uterine Cervical Neoplasms | COMPLETED | NCT01671462 |
| Blind Placement | Other | Approved | No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement | TERMINATED | NCT01275430 |
| Sherlock 3CG | Other | Approved | No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement | TERMINATED | NCT01275430 |
| Saline | Other | Phase PHASE2 | Ischemic Stroke | UNKNOWN | NCT02985060 |
| Standard treatment | Drug | Phase PHASE2 | Ischemic Stroke | UNKNOWN | NCT02985060 |
| Arctic Sun | Other | Phase PHASE2 | Ischemic Stroke | UNKNOWN | NCT02985060 |
| Saline | Other | Phase PHASE2 | Ischemic Stroke | UNKNOWN | NCT02985060 |
| Standard treatment | Drug | Phase PHASE2 | Ischemic Stroke | UNKNOWN | NCT02985060 |
| Arctic Sun | Other | Phase PHASE2 | Ischemic Stroke | UNKNOWN | NCT02985060 |
| Sysmex hematology analyzer KX-21 | Other | Preclinical | Acquired Immunodeficiency Syndrome | COMPLETED | NCT02396355 |
| BD FACSCalibur flow cytometer | Other | Preclinical | Acquired Immunodeficiency Syndrome | COMPLETED | NCT02396355 |
| Investigational BD FACSPresto System | Other | Preclinical | Acquired Immunodeficiency Syndrome | COMPLETED | NCT02396355 |
| Medtronic QuickSet Infusion Set | Other | Preclinical | Diabetes | COMPLETED | NCT02382536 |
| BD Scarlett Infusion set | Other | Preclinical | Diabetes | COMPLETED | NCT02382536 |
| Medtronic QuickSet Infusion Set | Other | Preclinical | Diabetes | COMPLETED | NCT02382536 |
| BD Scarlett Infusion set | Other | Preclinical | Diabetes | COMPLETED | NCT02382536 |
| Bard® LifeStent® Vascular Stent System | Other | Approved | Peripheral Vascular Disease | COMPLETED | NCT01179984 |
| Standard Uncoated Balloon Angioplasty Catheter | Other | Approved | Femoral Artery Stenosis | COMPLETED | NCT02063672 |
| Lutonix DCB | Other | Approved | Femoral Artery Stenosis | COMPLETED | NCT02063672 |
| Standard Uncoated Balloon Angioplasty Catheter | Other | Approved | Femoral Artery Stenosis | COMPLETED | NCT02063672 |
| Lutonix DCB | Other | Approved | Femoral Artery Stenosis | COMPLETED | NCT02063672 |
| MD-12-001 Stent | Other | Approved | Arterial Occlusive Disease | COMPLETED | NCT01746550 |
| MD-12-001 Stent | Other | Approved | Arterial Occlusive Disease | COMPLETED | NCT01746550 |
| training in optimal insulin injection technique | Other | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT04007003 |
| BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle | Device | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT04090242 |
| BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle | Device | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT04090242 |
| IUO Plasma Cell Disorders Panel | Other | Preclinical | Plasma Cell Disorder | COMPLETED | NCT05032339 |
| Blood Culture QI Program | Other | Approved | Bacteremia | COMPLETED | NCT01413555 |
| Blood Culture QI Program | Other | Approved | Bacteremia | COMPLETED | NCT01413555 |
| Vertebroplasty | Other | Approved | Vertebral Compression Fractures | COMPLETED | NCT01482793 |
| GBP CGM | Other | Phase PHASE2 | Type 1 Diabetes Mellitus | COMPLETED | NCT01469715 |
| GBP CGM | Other | Phase PHASE2 | Type 1 Diabetes Mellitus | COMPLETED | NCT01469715 |
| Standard uncoated Balloon Angioplasty Catheter | Other | Phase PHASE1 | Atherosclerosis | COMPLETED | NCT00930813 |
| Lutonix Catheter | Other | Phase PHASE1 | Atherosclerosis | COMPLETED | NCT00930813 |
| Medtronic Guardian CGM | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01093833 |
| YSI Glucose Analyzer | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01093833 |
| BD Continuous glucose monitor (BD CGM) | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01093833 |
| Medtronic Guardian CGM | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01093833 |
| YSI Glucose Analyzer | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01093833 |
| BD Continuous glucose monitor (BD CGM) | Other | Phase PHASE1 | Diabetes | COMPLETED | NCT01093833 |
| Lutonix Drug Coated Balloon Catheter | Drug | Preclinical | Peripheral Artery Disease | TERMINATED | NCT02043951 |
| Sham Endoscopy | Other | Phase PHASE3 | Obesity | TERMINATED | NCT00394212 |
| Transoral Suturing | Other | Phase PHASE3 | Obesity | TERMINATED | NCT00394212 |
| Sham Endoscopy | Other | Phase PHASE3 | Obesity | TERMINATED | NCT00394212 |
| Transoral Suturing | Other | Phase PHASE3 | Obesity | TERMINATED | NCT00394212 |
| Standard Uncoated Balloon Angioplasty Catheter | Other | Phase PHASE2 | Femoral Arterial Stenosis | COMPLETED | NCT01816412 |
| MD02-LDCB Paclitaxel coated balloon catheter | Other | Phase PHASE2 | Femoral Arterial Stenosis | COMPLETED | NCT01816412 |
| Standard Uncoated Balloon Angioplasty Catheter | Other | Phase PHASE2 | Femoral Arterial Stenosis | COMPLETED | NCT01816412 |
| MD02-LDCB Paclitaxel coated balloon catheter | Other | Phase PHASE2 | Femoral Arterial Stenosis | COMPLETED | NCT01816412 |
| Lutonix Drug Coated Balloon | Drug | Preclinical | Peripheral Artery Disease | COMPLETED | NCT01864278 |
| 5 mm Bard LifeStent Vascular Stent | Other | Preclinical | Peripheral Artery Disease | COMPLETED | NCT01920308 |
| LifeStent Vascular Stent | Other | Approved | Peripheral Artery Disease | COMPLETED | NCT02262949 |
| LifeStent Vascular Stent | Other | Approved | Peripheral Artery Disease | COMPLETED | NCT02262949 |
| Percutaneous Transluminal Angioplasty only | Other | Approved | Restenosis | COMPLETED | NCT01257438 |
| Fluency Plus Endovascular Stent Graft | Other | Approved | Restenosis | COMPLETED | NCT01257438 |
| True™ Flow Valvuloplasty Perfusion Catheter | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT02847546 |
| RS2 (RESTORe Suturing System) | Other | Phase PHASE1 | Obesity | COMPLETED | NCT00679848 |
| Lutonix Paclitaxel-Coated Balloon | Other | Phase PHASE1 | Coronary Artery Stenosis | COMPLETED | NCT00934752 |
| uncoated endotracheal tube | Other | Phase PHASE3 | Respiratory Failure | COMPLETED | NCT00148642 |
| silver salts coated endotracheal tube | Other | Phase PHASE3 | Respiratory Failure | COMPLETED | NCT00148642 |
| SHERLOCK 3CG™ Tip Confirmation System with MODUS Software | Other | Preclinical | Indication for Peripheral Intravenous Catheterization | COMPLETED | NCT03028090 |
| SHERLOCK 3CG™ Tip Confirmation System with MODUS Software | Other | Preclinical | Indication for Peripheral Intravenous Catheterization | COMPLETED | NCT03028090 |
| BD NEXT 32G x 4mm pen needle | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT01852136 |
| BD NEXT 31G x 8mm pen needle | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT01852136 |
| BD NEXT 31G x 5 mm pen needle | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT01852136 |
| BD NEXT 32G x 4mm pen needle | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT01852136 |
| BD NEXT 31G x 8mm pen needle | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT01852136 |
| BD NEXT 31G x 5 mm pen needle | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT01852136 |
| FLAIR™ Endovascular Stent Graft | Other | Approved | Constriction, Pathologic | COMPLETED | NCT00614315 |
| Bard silicone elastomer coated latex catheter system | Other | Phase PHASE4 | Catheterization | TERMINATED | NCT00482547 |
| Hydrogel Silver Salts Coated Latex Urinary Catheter System | Other | Phase PHASE4 | Catheterization | TERMINATED | NCT00482547 |
| Bard silicone elastomer coated latex catheter system | Other | Phase PHASE4 | Catheterization | TERMINATED | NCT00482547 |
| Hydrogel Silver Salts Coated Latex Urinary Catheter System | Other | Phase PHASE4 | Catheterization | TERMINATED | NCT00482547 |
| Bard Luminexx Iliac Stent and Delivery System | Other | Approved | Iliac Artery Occlusive Disease | COMPLETED | NCT00561457 |
| Bard Luminexx Iliac Stent and Delivery System | Other | Approved | Iliac Artery Occlusive Disease | COMPLETED | NCT00561457 |
| Conventional IV Catheter Device | Device | Approved | Vascular Access Complication | COMPLETED | NCT01943474 |
| AccuCath IV Catheter Device | Device | Approved | Vascular Access Complication | COMPLETED | NCT01943474 |
| PTA | Other | Approved | Stenosis of Vascular Prosthetic Devices, Implants and Grafts | COMPLETED | NCT00677235 |
| FLAIR Endovascular Stent Graft | Other | Approved | Stenosis of Vascular Prosthetic Devices, Implants and Grafts | COMPLETED | NCT00677235 |
| Ajust Adjustable Single-Incision Sling | Other | Approved | Female Stress Urinary Incontinence | COMPLETED | NCT01290796 |
| Progel® Pleural Air Leak Sealant | Other | Approved | Pulmonary Disease | COMPLETED | NCT01867658 |
| Peripherally Inserted Central Catheter (PICC) | Other | Approved | Indication for PICC Placement | COMPLETED | NCT02498821 |
| Sherlock 3CG® TCS | Other | Approved | Indication for PICC Placement | COMPLETED | NCT02498821 |
| Chest X-ray | Other | Approved | Indication for PICC Placement | COMPLETED | NCT02498821 |
| Gelfoam Plus | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01959503 |
| Progel Vascular Sealant | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01959503 |
| Gelfoam Plus | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01959503 |
| Progel Vascular Sealant | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01959503 |
| Conventional vascular access | Other | Approved | Vascular Access Complication | TERMINATED | NCT00914069 |
| RIVS vascular access | Other | Approved | Vascular Access Complication | TERMINATED | NCT00914069 |
| AccuCath 2.25" BC Intravascular Catheter | Other | Approved | Vascular Access Complication | COMPLETED | NCT02449798 |
| AccuCath Intravenous Catheter System | Other | Approved | Vascular Access Complication | COMPLETED | NCT01937195 |
| ECG-guided PICC placement | Other | Approved | Primary Focus: Adult Subjects Who Require PICC Placement | TERMINATED | NCT00742053 |
| MiniMed® Quick-set® | Other | Approved | Diabetes Mellitus, Type 1 | WITHDRAWN | NCT03242005 |
| MiniMed® Pro-set® | Other | Approved | Diabetes Mellitus, Type 1 | WITHDRAWN | NCT03242005 |
| MiniMed® Quick-set® | Other | Approved | Diabetes Mellitus, Type 1 | WITHDRAWN | NCT03242005 |
| MiniMed® Pro-set® | Other | Approved | Diabetes Mellitus, Type 1 | WITHDRAWN | NCT03242005 |
| Conventional IV Catheter System | Other | Approved | Vascular Access Complications | COMPLETED | NCT01940354 |
| AccuCath IV Catheter System | Other | Approved | Vascular Access Complications | COMPLETED | NCT01940354 |
| Colposcopy/biopsy | Other | Approved | Uterine Cervical Neoplasm | TERMINATED | NCT03020121 |
| Colposcopy/biopsy | Other | Approved | Uterine Cervical Neoplasm | TERMINATED | NCT03020121 |
| Long term PAC placement | Other | Phase PHASE3 | Breast Cancer | WITHDRAWN | NCT02784730 |
| Iterative PICC placement | Other | Phase PHASE3 | Breast Cancer | WITHDRAWN | NCT02784730 |
| Target-Controlled Infusion | Other | Approved | Shoulder Dislocation | UNKNOWN | NCT03442803 |
| Resorbable Mesh | Other | Approved | Ventral Hernia | COMPLETED | NCT02053168 |
| Colposcopy | Other | Approved | Uterine Cervical Neoplasms | COMPLETED | NCT01944722 |
| BD Onclarity™ HPV assay on BD Viper™ LT | Other | Approved | Uterine Cervical Neoplasms | COMPLETED | NCT01944722 |
| Colposcopy | Other | Approved | Uterine Cervical Neoplasms | COMPLETED | NCT01944722 |
| BD Onclarity™ HPV assay on BD Viper™ LT | Other | Approved | Uterine Cervical Neoplasms | COMPLETED | NCT01944722 |
| Colposcopy | Other | Approved | Uterine Cervical Neoplasms | COMPLETED | NCT01944722 |
| BD Onclarity™ HPV assay on BD Viper™ LT | Other | Approved | Uterine Cervical Neoplasms | COMPLETED | NCT01944722 |
| Bard® LifeStent® 5F Vascular Stent System | Other | Preclinical | Peripheral Arterial Disease | COMPLETED | NCT03071146 |
| BDMax Vaginal Panel | Other | Preclinical | Vaginitis | COMPLETED | NCT03151928 |
| BDMax Vaginal Panel | Other | Preclinical | Vaginitis | COMPLETED | NCT03151928 |
| Bard® LifeStent® Vascular Stent System | Other | Approved | Peripheral Vascular Disease | COMPLETED | NCT01179984 |
| Other Commercially Available Pen Needles (Unifine® Pentips®/Mylife Clickfine®) vs Nucleus | Other | Approved | Diabetes | COMPLETED | NCT03267264 |
| NovoTwist®/NovoFine® Plus vs Nucleus | Other | Approved | Diabetes | COMPLETED | NCT03267264 |
| NovoFine® vs Nucleus | Other | Approved | Diabetes | COMPLETED | NCT03267264 |
| BD Nano™ vs Nucleus | Other | Approved | Diabetes | COMPLETED | NCT03267264 |
| Conventional Port | Other | Approved | Power Port | COMPLETED | NCT02887261 |
| "Bard"PowerPort sip Implantable Port | Other | Approved | Power Port | COMPLETED | NCT02887261 |
| Lutonix Drug Coated Balloon | Drug | Preclinical | Peripheral Artery Disease | COMPLETED | NCT02278991 |
| PTA followed by placement of LifeStent® Vascular Stent | Other | Approved | Superficial Femoral Artery Stenosis | TERMINATED | NCT00908947 |
| Simple Diagnostics Comfort EZ™ | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| 34G Artsana Insupen Extr3me | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| 33G Artsana Insupen Extr3me | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| BD Nano™ PRO | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| Simple Diagnostics Comfort EZ™ | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| 34G Artsana Insupen Extr3me | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| 33G Artsana Insupen Extr3me | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| BD Nano™ PRO | Other | Approved | Diabetes | COMPLETED | NCT03878758 |
| Lutonix Drug Coated Balloon | Drug | Approved | Peripheral Artery Disease | COMPLETED | NCT01628159 |
| BD Nano™ PRO 32G pen needle | Other | Approved | Diabetes | COMPLETED | NCT03878745 |
| Terumo Nanopass® 34G pen needle | Other | Approved | Diabetes | COMPLETED | NCT03878745 |
| BD Nano™ PRO 32G pen needle | Other | Approved | Diabetes | COMPLETED | NCT03878745 |
| Terumo Nanopass® 34G pen needle | Other | Approved | Diabetes | COMPLETED | NCT03878745 |
| PTA (Lutonix® 035 DCB Catheter) | Other | Approved | Peripheral Arterial Disease | COMPLETED | NCT02424383 |
| Standard PTA Balloon | Other | Approved | Peripheral Artery Disease | COMPLETED | NCT01790243 |
| Lutonix Drug Coated Balloon | Drug | Approved | Peripheral Artery Disease | COMPLETED | NCT01790243 |
| Detection and isolation of C. difficile carriers | Other | Approved | Clostridium Difficile | COMPLETED | NCT03223415 |
| Detection and isolation of C. difficile carriers | Other | Approved | Clostridium Difficile | COMPLETED | NCT03223415 |
| PleurX catheter | Other | Approved | Ascites Hepatic | COMPLETED | NCT04569565 |
| PleurX catheter | Other | Approved | Ascites Hepatic | COMPLETED | NCT04569565 |
| PleurX catheter | Other | Approved | Ascites Hepatic | COMPLETED | NCT04569565 |
| LIFESTREAM™ covered stent | Other | Approved | Peripheral Artery Disease | COMPLETED | NCT02228564 |
| Percutaneous transluminal angioplasty (PTA) | Other | Approved | Peripheral Artery Disease | COMPLETED | NCT02228564 |
| 4mm needles | Other | Approved | Diabetes Mellitus | COMPLETED | NCT04659330 |
| Online education (BdandMe) for injection technique | Other | Approved | Diabetes Mellitus | COMPLETED | NCT04659330 |
| 4mm needles | Other | Approved | Diabetes Mellitus | COMPLETED | NCT04659330 |
| Online education (BdandMe) for injection technique | Other | Approved | Diabetes Mellitus | COMPLETED | NCT04659330 |
| CATERPILLAR™ Arterial Embolization Device | Device | Approved | Embolization, Therapeutic | COMPLETED | NCT04090320 |
| LTX DCB | Other | Approved | Femoral Artery Stenosis | COMPLETED | NCT02720003 |
| Resorbable Mesh | Other | Approved | Ventral Hernia | COMPLETED | NCT01961687 |
| Resorbable Mesh | Other | Approved | Ventral Hernia | COMPLETED | NCT01961687 |
| Colposcopy | Other | Preclinical | Cervical Neoplasms | COMPLETED | NCT02267876 |
| BD HPV Assay on Viper LT | Other | Preclinical | Cervical Neoplasms | COMPLETED | NCT02267876 |
| Cue(TM) Needle Tracking Technology | Other | Preclinical | Catheter Related Complication | COMPLETED | NCT04811430 |
| Randomized Traditional | Other | Preclinical | Catheter Related Complication | COMPLETED | NCT04811430 |
| Artic Sun | Other | Approved | Hypothermia | UNKNOWN | NCT04825418 |
| Artic Sun | Other | Approved | Hypothermia | UNKNOWN | NCT04825418 |
| Saline Control | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03229759 |
| Vehicle Control | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03229759 |
| Octenidine Dihydrocloride in aqueous solution | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03229759 |
| Saline Control | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03229759 |
| Vehicle Control | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03229759 |
| Octenidine Dihydrocloride in aqueous solution | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03229759 |
| Saline | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| ChloraPrep | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| OCT- tinted | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| OCT - clear | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| Saline | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| ChloraPrep | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| OCT- tinted | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| OCT - clear | Other | Phase PHASE2 | Preoperative Skin Preparation | COMPLETED | NCT03224299 |
| Standard education on injection technique | Other | Approved | Insulin Injections and Lipohypertrophy | TERMINATED | NCT02271594 |
| Intensive Training on Best Insulin Injection Technique | Other | Approved | Insulin Injections and Lipohypertrophy | TERMINATED | NCT02271594 |
| Standard education on injection technique | Other | Approved | Insulin Injections and Lipohypertrophy | TERMINATED | NCT02271594 |
| Intensive Training on Best Insulin Injection Technique | Other | Approved | Insulin Injections and Lipohypertrophy | TERMINATED | NCT02271594 |
| BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle | Device | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT04090242 |
| ProGEL Pleural Air Leak Sealant without standard surgical closure | Other | Approved | Lung Cancer | COMPLETED | NCT01394978 |
| ProGEL Pleural Air Leak Sealant with standard surgical closure | Other | Approved | Lung Cancer | COMPLETED | NCT01394978 |
| Control | Other | Approved | Lung Cancer | COMPLETED | NCT01394978 |
| viral culture | Other | Preclinical | Covid19 | WITHDRAWN | NCT04812327 |
| rt-PCR | Other | Preclinical | Covid19 | WITHDRAWN | NCT04812327 |
| BD Veritor Plus System for Rapid Detection of SARS CoV-2 | Other | Preclinical | Covid19 | WITHDRAWN | NCT04812327 |
| viral culture | Other | Preclinical | Covid19 | WITHDRAWN | NCT04812327 |
| rt-PCR | Other | Preclinical | Covid19 | WITHDRAWN | NCT04812327 |
| BD Veritor Plus System for Rapid Detection of SARS CoV-2 | Other | Preclinical | Covid19 | WITHDRAWN | NCT04812327 |
| Negative Control | Other | Preclinical | Microbial Colonization | COMPLETED | NCT04035161 |
| Active Comparator | Other | Preclinical | Microbial Colonization | COMPLETED | NCT04035161 |
| Reference Standard | Other | Preclinical | Microbial Colonization | COMPLETED | NCT04035161 |
| Investigational Product | Other | Preclinical | Microbial Colonization | COMPLETED | NCT04035161 |
| StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip) | Device | Preclinical | Peripheral Intravenous Catheter Stabilization | COMPLETED | NCT04845906 |
| Securis™ Stabilization Device | Device | Preclinical | Peripheral Intavenous Catheter Stabilization | COMPLETED | NCT04841330 |
| Securis™ Stabilization Device | Device | Preclinical | Peripheral Intavenous Catheter Stabilization | COMPLETED | NCT04841330 |
| Securis™ Stabilization Device | Device | Preclinical | Peripheral Intavenous Catheter Stabilization | COMPLETED | NCT04841330 |
| Xen Matrix AB | Other | Approved | Incisional Hernia | COMPLETED | NCT02691962 |
| Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon | Other | Approved | Stenosis | COMPLETED | NCT02649946 |
| Covera Vascular Covered Stent following PTA | Other | Approved | Stenosis | COMPLETED | NCT02649946 |
| Medtronic iPro2 Professional CGM | Other | Approved | Diabetes | COMPLETED | NCT01645696 |
| BD CGM without Outer Layer | Other | Approved | Diabetes | COMPLETED | NCT01645696 |
| BD CGM with Outer Layer | Other | Approved | Diabetes | COMPLETED | NCT01645696 |
| Medtronic iPro2 Professional CGM | Other | Approved | Diabetes | COMPLETED | NCT01645696 |
| BD CGM without Outer Layer | Other | Approved | Diabetes | COMPLETED | NCT01645696 |
| BD CGM with Outer Layer | Other | Approved | Diabetes | COMPLETED | NCT01645696 |
| P4HB product | Other | Preclinical | Plastic Surgery | COMPLETED | NCT04195854 |
| Uncoated PTA Catheter | Other | Approved | Critical Limb Ischemia | COMPLETED | NCT01870401 |
| Lutonix DCB | Other | Approved | Critical Limb Ischemia | COMPLETED | NCT01870401 |
| 8mm x 31G pen needle (Short) | Other | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT01334606 |
| 4 mm x 32G pen needle (Nano) | Other | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT01334606 |
| 8mm x 31G pen needle (Short) | Other | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT01334606 |
| 4 mm x 32G pen needle (Nano) | Other | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT01334606 |
| Endovascular revascularization of peripheral arteries | Other | Preclinical | Vascular Diseases, Peripheral | COMPLETED | NCT04765566 |
| 20-gauge BD Nexiva Diffusics | Other | Approved | Plasma Exchange | COMPLETED | NCT04253756 |
| catheter placement | Other | Approved | Catheterization | COMPLETED | NCT04719377 |
| catheter placement | Other | Approved | Catheterization | COMPLETED | NCT04719377 |
| catheter placement | Other | Approved | Catheterization | COMPLETED | NCT04719377 |
| Lutonix 035 Drug Coated Balloon PTA Catheter, Model 9004 | Drug | Preclinical | Arteriovenous Fistula | COMPLETED | NCT02746159 |
| HPV DNA test | Other | Preclinical | Uterine Cervical Neoplasms | TERMINATED | NCT01234480 |
| colposcopy with biopsy/ECC | Other | Preclinical | Uterine Cervical Neoplasms | TERMINATED | NCT01234480 |
| BD SurePath Pap test | Other | Preclinical | Uterine Cervical Neoplasms | TERMINATED | NCT01234480 |
| BD SurePath Plus Pap test | Other | Preclinical | Uterine Cervical Neoplasms | TERMINATED | NCT01234480 |
| BD Veritor Professional | Other | Preclinical | Upper Respiratory Infection | COMPLETED | NCT05352581 |
| BD Veritor At-Home | Other | Preclinical | Upper Respiratory Infection | COMPLETED | NCT05352581 |
| BD Veritor Professional | Other | Preclinical | Upper Respiratory Infection | COMPLETED | NCT05352581 |
| BD Veritor At-Home | Other | Preclinical | Upper Respiratory Infection | COMPLETED | NCT05352581 |
| Caterpillar™ Arterial Embolization Device | Device | Approved | Embolization, Therapeutic | COMPLETED | NCT04244370 |
| molecular assays to screen for eXDR | Other | Preclinical | Multidrug-resistant Bacteria Screening | COMPLETED | NCT05200546 |
| molecular assays to screen for eXDR | Other | Preclinical | Multidrug-resistant Bacteria Screening | COMPLETED | NCT05200546 |
| Body-temperature circulated water | Other | Approved | Healthy | COMPLETED | NCT04973085 |
| Cold circulated water | Other | Approved | Healthy | COMPLETED | NCT04973085 |
| Body-temperature circulated water | Other | Approved | Healthy | COMPLETED | NCT04973085 |
| Cold circulated water | Other | Approved | Healthy | COMPLETED | NCT04973085 |
| IUO Plasma Cell Disorders Panel | Other | Preclinical | Plasma Cell Disorder | COMPLETED | NCT05032339 |
| IUO Plasma Cell Disorders Panel | Other | Preclinical | Plasma Cell Disorder | COMPLETED | NCT05032339 |
| Indwelling Pleural Catheter Insertion and Talc Pleurodesis | Other | Approved | Pleural Effusion, Malignant | COMPLETED | NCT02517749 |
| Chest Drain Insertion and Talc Pleurodesis | Other | Approved | Pleural Effusion, Malignant | COMPLETED | NCT02517749 |
| Optimal insulin injection | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT04120974 |
| Optimal insulin injection | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT04120974 |
| Optimal insulin injection | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT04120974 |
| IUO CLPD Limited Panel | Other | Preclinical | Chronic Lymphoproliferative Diseases (CLPD) | COMPLETED | NCT05032313 |
| IUO CLPD Limited Panel | Other | Preclinical | Chronic Lymphoproliferative Diseases (CLPD) | COMPLETED | NCT05032313 |
| IUO CLPD Limited Panel | Other | Preclinical | Chronic Lymphoproliferative Diseases (CLPD) | COMPLETED | NCT05032313 |
| PTA (UltraScore Focused Force PTA Balloon) | Other | Preclinical | Peripheral Arterial Disease | COMPLETED | NCT03193619 |
| PTA (UltraScore Focused Force PTA Balloon) | Other | Preclinical | Peripheral Arterial Disease | COMPLETED | NCT03193619 |
| Peripheral Intravenous Catheter | Other | Approved | Indication for Peripheral Intravenous Catheterisation | COMPLETED | NCT04344314 |
| Intravenous Access Device Flushing | Device | Approved | Effectiveness and Safety of Pre-filled Flush Syringe | COMPLETED | NCT05763147 |
| Intravenous Access Device Flushing | Device | Approved | Effectiveness and Safety of Pre-filled Flush Syringe | COMPLETED | NCT05763147 |
| IUO Acute Leukemia Panel | Other | Preclinical | Acute Leukemia | COMPLETED | NCT05035615 |
| Spinal needle | Other | Preclinical | Analgesia | COMPLETED | NCT05214560 |
| Spinal needle | Other | Preclinical | Analgesia | COMPLETED | NCT05214560 |
| Peripherally Inserted Central Catheter | Other | Preclinical | Peripherally Inserted Central Catheter | COMPLETED | NCT04263649 |
| Sage PrimoFit | Other | Approved | Non-invasive Urine Output Management | COMPLETED | NCT05955560 |
| PureWick Male External Catheter | Other | Approved | Non-invasive Urine Output Management | COMPLETED | NCT05955560 |
| Sage PrimoFit | Other | Approved | Non-invasive Urine Output Management | COMPLETED | NCT05955560 |
| PureWick Male External Catheter | Other | Approved | Non-invasive Urine Output Management | COMPLETED | NCT05955560 |
| Arista | Other | Phase PHASE1 | Blood Loss, Surgical | COMPLETED | NCT05522153 |
| Arista | Other | Phase PHASE1 | Blood Loss, Surgical | COMPLETED | NCT05522153 |
| 12.7mm x 29G Pen Needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01231984 |
| 8mm x 31G Pen Needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01231984 |
| 4 mm x 32G Pen Needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01231984 |
| 12.7mm x 29G Pen Needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01231984 |
| 8mm x 31G Pen Needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01231984 |
| 4 mm x 32G Pen Needle | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01231984 |
| BD OneFlow LST, and B-CLPD T1 to T4 Assays | Other | Preclinical | Chronic Lymphoproliferative Diseases (CLPD) | COMPLETED | NCT05557422 |
| BD OneFlow LST, and B-CLPD T1 to T4 Assays | Other | Preclinical | Chronic Lymphoproliferative Diseases (CLPD) | COMPLETED | NCT05557422 |
| BD OneFlow LST, and B-CLPD T1 to T4 Assays | Other | Preclinical | Chronic Lymphoproliferative Diseases (CLPD) | COMPLETED | NCT05557422 |
| WavelinQ™ EndoAVF System | Other | Approved | End Stage Kidney Disease | TERMINATED | NCT04626427 |
| BD PureHub™ Disinfecting Cap Placements: Attachments/removals | Other | Approved | Catheter Related Complication | COMPLETED | NCT05130762 |
| BD PureHub™ Disinfecting Cap Placements: Attachments/removals | Other | Approved | Catheter Related Complication | COMPLETED | NCT05130762 |
| BD PureHub™ Disinfecting Cap Placements: Attachments/removals | Other | Approved | Catheter Related Complication | COMPLETED | NCT05130762 |
| Home wear first | Other | Approved | Healthy Volunteers | COMPLETED | NCT05553418 |
| In-clinic wear first | Other | Approved | Healthy Volunteers | COMPLETED | NCT05553418 |
| Arm A - Application of 5g of ARISTA™ AH | Other | Approved | Prostate Cancer (Adenocarcinoma) | RECRUITING | NCT06822036 |
| New Indwelling Pleural Catheter | Other | Approved | Malignant Pleural Effusions | COMPLETED | NCT02227732 |
| Endovascular AVF (EndoAVF) | Other | Approved | Chronic Kidney Disease (CKD) | COMPLETED | NCT02119845 |
| Standard surgery | Procedure | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| GalaFLEX LITE™ Scaffold | Other | Approved | Capsular Contracture Associated With Breast Implant | RECRUITING | NCT05945329 |
| alcoholic chlorhexidine | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01841242 |
| alcoholic povidone iodine | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01841242 |
| alcoholic chlorhexidine | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01841242 |
| alcoholic povidone iodine | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01841242 |
| UltraFlex™ Self-Adhering Male External Catheter | Other | Approved | Urinary Incontinence | COMPLETED | NCT06850259 |
| PureWick™ System | Other | Approved | Urinary Incontinence | COMPLETED | NCT06850259 |
| UltraFlex™ Self-Adhering Male External Catheter | Other | Approved | Urinary Incontinence | COMPLETED | NCT06850259 |
| PureWick™ System | Other | Approved | Urinary Incontinence | COMPLETED | NCT06850259 |
| UltraFlex™ Self-Adhering Male External Catheter | Other | Approved | Urinary Incontinence | COMPLETED | NCT06850259 |
| PureWick™ System | Other | Approved | Urinary Incontinence | COMPLETED | NCT06850259 |
| HPV Genotyping Nucleic Acid Assay Kit | Other | Approved | Cervical Cancer | COMPLETED | NCT04461678 |
| HPV Genotyping Nucleic Acid Assay Kit | Other | Approved | Cervical Cancer | COMPLETED | NCT04461678 |
| Hollister® Female Urinary Pouch External Collection Device | Device | Approved | Nocturnal Enuresis | COMPLETED | NCT05710718 |
| PureWick™ System | Other | Approved | Nocturnal Enuresis | COMPLETED | NCT05710718 |
| Hollister® Female Urinary Pouch External Collection Device | Device | Approved | Nocturnal Enuresis | COMPLETED | NCT05710718 |
| PureWick™ System | Other | Approved | Nocturnal Enuresis | COMPLETED | NCT05710718 |
| Hollister Female Urinary Pouch External Collection Device | Device | Approved | Adult Nocturnal Enuresis | COMPLETED | NCT06666426 |
| PureWick System | Other | Approved | Adult Nocturnal Enuresis | COMPLETED | NCT06666426 |
| Hollister Female Urinary Pouch External Collection Device | Device | Approved | Adult Nocturnal Enuresis | COMPLETED | NCT06666426 |
| PureWick System | Other | Approved | Adult Nocturnal Enuresis | COMPLETED | NCT06666426 |
| BD Onclarity™ HPV assay | Other | Preclinical | Cervical Intraepithelial Neoplasia Grade 2/3 | COMPLETED | NCT04788849 |
| BD Onclarity™ HPV assay | Other | Preclinical | Cervical Intraepithelial Neoplasia Grade 2/3 | COMPLETED | NCT04788849 |
| PureWick System | Other | Approved | Healthy Volunteers, Adolescent | COMPLETED | NCT06631313 |
| control Aerobic/F Culture Vials | Other | Preclinical | Sepsis | COMPLETED | NCT06426121 |
| test Aerobic/F Culture Vials | Other | Preclinical | Sepsis | COMPLETED | NCT06426121 |
| control Aerobic/F Culture Vials | Other | Preclinical | Sepsis | COMPLETED | NCT06426121 |
| test Aerobic/F Culture Vials | Other | Preclinical | Sepsis | COMPLETED | NCT06426121 |
| Endovasccular AVF (EndoAVF) | Other | Approved | Chronic Kidney Disease (CKD) | COMPLETED | NCT02119832 |
| The FLEX System will be used to percutaneously create a fistula in CKD patients who require hemodialysis vascular access | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT02036671 |
| The FLEX System will be used to percutaneously create a fistula in CKD patients who require hemodialysis vascular access | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT02036671 |
| Tegaderm CHG | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01112020 |
| Biopatch | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01112020 |
| CHG Catheter Dressing Patch | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01112020 |
| Povidone iodine | Other | Phase PHASE3 | Healthy | COMPLETED | NCT00692484 |
| Chlorhexidine gluconate | Other | Phase PHASE3 | Healthy | COMPLETED | NCT00692484 |
| everlinQ endoAVF System | Other | Approved | Chronic Kidney Diseases | COMPLETED | NCT03708770 |
| everlinQ endoAVF System | Other | Approved | Chronic Kidney Diseases | COMPLETED | NCT03708562 |
| everlinQ endoAVF System | Other | Approved | Chronic Kidney Disease | TERMINATED | NCT02682420 |
| everlinQ endoAVF System | Other | Approved | Chronic Kidney Disease | TERMINATED | NCT02682420 |
| Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC) | Other | Approved | Malignant Pleural Effusion | COMPLETED | NCT02649894 |
| Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter | Other | Approved | Malignant Pleural Effusion | COMPLETED | NCT02649894 |
| 70% isopropyl alcohol | Other | Phase PHASE4 | Antimicrobial Effectiveness | COMPLETED | NCT01366417 |
| ChloraPrep One-Step | Other | Phase PHASE4 | Antimicrobial Effectiveness | COMPLETED | NCT01366417 |
| 70% isopropyl alcohol | Other | Phase PHASE4 | Antimicrobial Effectiveness | COMPLETED | NCT01314703 |
| ChloraPrep One-Step | Other | Phase PHASE4 | Antimicrobial Effectiveness | COMPLETED | NCT01314703 |
| UltraFlex Self-Adhering Male External Catheter | Other | Approved | Urinary Incontinence | ENROLLING_BY_INVITATION | NCT07282860 |
| PureWick System | Other | Approved | Urinary Incontinence | ENROLLING_BY_INVITATION | NCT07282860 |
| Covera Vascular Covered Stent | Other | Approved | Arteriovenous Fistula | COMPLETED | NCT04261686 |
| Rotarex(TM) Rotational Excisional Atherectomy System | Other | Approved | Peripheral Arterial Disease(PAD) | RECRUITING | NCT07016698 |
| BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes | Other | Preclinical | Anesthesia | COMPLETED | NCT05953363 |
| BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes | Other | Preclinical | Anesthesia | COMPLETED | NCT05953363 |
| BD™ Sirolimus Drug Coated Balloon Catheter percutaneous transluminal angioplasty | Drug | Approved | Peripheral Arterial Disease | COMPLETED | NCT05556681 |
| BD SiteRite(TM) 9 | Other | Preclinical | BD SiteRite 9 for VAD Insertion | COMPLETED | NCT06632509 |
| BD SiteRite(TM) 9 | Other | Preclinical | BD SiteRite 9 for VAD Insertion | COMPLETED | NCT06632509 |
| BD Prevue(TM) II | Other | Preclinical | BD Prevue II for Peripheral Intravenous Catheter Placement | COMPLETED | NCT06632496 |
| BD Prevue(TM) II | Other | Preclinical | BD Prevue II for Peripheral Intravenous Catheter Placement | COMPLETED | NCT06632496 |
| PureWick System | Other | Approved | Nocturia | SUSPENDED | NCT05090722 |
| PureWick System | Other | Approved | Nocturia | SUSPENDED | NCT05090722 |
| PIVO-Pro needle-free blood collection device | Device | Approved | Blood Culture Contamination | RECRUITING | NCT06806709 |
| PIVO-Pro needle-free blood collection device | Device | Approved | Blood Culture Contamination | RECRUITING | NCT06806709 |
| PIVO-Pro needle-free blood collection device | Device | Approved | Blood Culture Contamination | RECRUITING | NCT06806709 |
| TissuePatch Sealant Film | Other | Preclinical | Post-operative Air Leaks | NOT_YET_RECRUITING | NCT06934486 |
| BD PosiFlush™ | Other | Approved | CRBSI - Catheter Related Bloodstream Infection | RECRUITING | NCT06604026 |
| BD PosiFlush™ SafeScrub | Other | Approved | CRBSI - Catheter Related Bloodstream Infection | RECRUITING | NCT06604026 |
| BD PosiFlush™ | Other | Approved | CRBSI - Catheter Related Bloodstream Infection | RECRUITING | NCT06604026 |
| BD PosiFlush™ SafeScrub | Other | Approved | CRBSI - Catheter Related Bloodstream Infection | RECRUITING | NCT06604026 |
| Mesh Implantation | Other | Approved | Ileostomy - Stoma | TERMINATED | NCT04916067 |
| Mesh Implantation | Other | Approved | Ileostomy - Stoma | TERMINATED | NCT04916067 |
| Mesh Implantation | Other | Approved | Ileostomy - Stoma | TERMINATED | NCT04916067 |
| Current practice - Community-based lunch cancer screening (LungTalk) | Other | Approved | Lung Cancer | COMPLETED | NCT06052449 |
| Social determinants of health screening assessment and referral process | Other | Approved | Lung Cancer | COMPLETED | NCT06052449 |
| Current practice - Community-based lunch cancer screening (LungTalk) | Other | Approved | Lung Cancer | COMPLETED | NCT06052449 |
| Social determinants of health screening assessment and referral process | Other | Approved | Lung Cancer | COMPLETED | NCT06052449 |
| Venclose MAVEN System (digiRF generator w MAVEN catheter) | Other | Approved | Venous Reflux | ACTIVE_NOT_RECRUITING | NCT05504070 |
| Venclose System (digiRF generator w EVSRF catheter) | Other | Approved | Venous Reflux | ACTIVE_NOT_RECRUITING | NCT05504070 |
| Venclose MAVEN System (digiRF generator w MAVEN catheter) | Other | Approved | Venous Reflux | ACTIVE_NOT_RECRUITING | NCT05504070 |
| Venclose System (digiRF generator w EVSRF catheter) | Other | Approved | Venous Reflux | ACTIVE_NOT_RECRUITING | NCT05504070 |
| LUTONIX 035 Drug Coated Balloon PTA Catheter | Drug | Approved | Arteriovenous Fistula | ACTIVE_NOT_RECRUITING | NCT03506308 |
| Chest X-Ray | Other | Phase PHASE2 | Advanced Cancer | ACTIVE_NOT_RECRUITING | NCT00761618 |
| IPC Placement | Other | Phase PHASE2 | Advanced Cancer | ACTIVE_NOT_RECRUITING | NCT00761618 |
| Intrapleural catheter (IPC) drained | Other | Phase PHASE2 | Advanced Cancer | ACTIVE_NOT_RECRUITING | NCT00761618 |
Total products: 451